Delaware
(State
or Other Jurisdiction of Incorporation or Organization)
|
5615
Scotts Valley Drive, Suite 110
Scotts
Valley, California 95066
(831) 438-8200
|
77-0390628
(I.R.S.
Employer
Identification
Number)
|
Large
accelerated filer o
|
Accelerated
filer o
|
Non-accelerated
filer o
|
Smaller
reporting company þ
|
Title
of Each Class of Shares To Be Registered
|
Amount
to be Registered (1)
|
Proposed
Maximum Offering Price Per Unit
|
Proposed
Maximum Aggregate Offering Price
|
Amount
of Registration Fee
|
Common
Stock, par value $0.0001 per share
|
10,427,888
|
$1.969(2)
|
$20,532,511.47(2)
|
$1,550.70(3)
|
(1)
|
The
shares of common stock being registered hereunder include (i) 2,380,942
shares of common stock being registered for resale by certain stockholders
of the Registrant, and (ii) (x) 3,246,959 shares of common stock issuable
upon exercise of the Series I Warrants, (y) up to 2,419,045 shares of
common stock issuable upon exercise of the Series II Warrants, and (z)
2,380,942 shares of common stock issuable upon exercise of the Series III
Warrants, being registered for resale by certain warrant holders of the
Registrant. Pursuant to Rule 416(a) under the Securities Act, this
registration statement also covers such number of additional shares of
common stock, of a currently indeterminable amount, as may from time to
time become issuable by reason of stock splits, stock dividends or similar
transactions.
|
(2)
|
Estimated
solely for the purpose of calculating the registration fee pursuant to
Rule 457(c) under the Securities Act, based upon the average of the high
and low sales prices of the registrant’s common stock, as reported on the
NYSE Amex on November 5, 2009.
|
(3)
|
Previously
paid.
|
ABOUT
THIS PROSPECTUS
|
ii
|
SUMMARY
|
1
|
RISK
FACTORS
|
7
|
DIVIDEND
POLICY
|
20
|
SELECTED
FINANCIAL DATA
|
20
|
SELECTED
QUARTERLY FINANCIAL DATA
|
20
|
USE
OF PROCEEDS
|
21
|
THE
PRIVATE PLACEMENT TRANSACTION
|
21
|
MANAGEMENT
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
|
22
|
CHANGES
IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL
DISCLOSURE
|
30
|
QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
30
|
BUSINESS
|
31
|
MANAGEMENT
|
40
|
EXECUTIVE
COMPENSATION DISCUSSION AND ANALYSIS
|
43
|
CORPORATE
GOVERNANCE
|
52
|
SELLING
SECURITY HOLDERS
|
59
|
PLAN
OF DISTRIBUTION
|
63
|
DESCRIPTION
OF SECURITIES
|
65
|
MARKET
PRICE OF AND DIVIDENDS ON COMMON EQUITY AND RELATED STOCKHOLDER
MATTERS
|
69
|
LEGAL
PROCEEDINGS
|
71
|
LEGAL
MATTERS
|
72
|
EXPERTS
|
72 |
WHERE
YOU CAN FIND MORE INFORMATION
|
73
|
COMMISSION
POSITION ON INDEMNIFICATION
|
73
|
PROVISION
FOR INDEMNIFICATION
|
73
|
FINANCIAL
STATEMENTS
|
F-1
|
Background
|
We
have filed this registration statement on Form S- 1 to register shares of our common stock and shares
of our common stock underlying the Series I Warrants, the Series II
Warrants and the Series III Warrants issued in a private placement
transaction on September 11, 2009.
|
Securities
Offered Pursuant to this Prospectus
|
2,380,942
shares of common stock and an aggregate of 8,046,946 shares of common
stock underlying the warrants issued in the private placement transaction,
comprised of:
-
3,246,959 shares of common stock underlying the Series I Warrants with an
exercise price of $3.93 per share, of which (i) up to 627,923 shares of
common stock are issuable pursuant to certain anti-dilution adjustment
provisions in the Series I Warrants, and (ii) 238,094 shares of common
stock are issuable pursuant to a warrant issued to Dawson James
Securities, Inc., the placement agent in connection with the private
placement transaction;
-
2,419,045 shares of common stock underlying the Series II Warrants
exercisable on a cashless basis with an exercise price of $0.01 per share;
and
-
2,380,942 shares of common stock underlying the Series III Warrants with
an exercise price of $2.52 per share.
|
Transaction
Proceeds
|
Assuming
the cash exercise of the Series I and Series III Warrants, and including
the cash proceeds received by us from the sale of common stock issued to
the investors at the closing, we will receive gross proceeds of
approximately $22,292,759 from this transaction. We anticipate
that all net proceeds obtained by us from the transaction will be used for
our working capital purposes. See “Use of Proceeds”
for further detail about how we intend to use the proceeds under varying
conditions.
Any
proceeds from the sale of the securities offered by this prospectus will
be received by the selling security holders for their own account, and we
will not receive any proceeds from the sale of any securities offered by
this prospectus.
|
NYSE
Amex symbol for our common stock
|
Our
common stock is listed on the NYSE Amex under the symbol
“VHC”.
|
|
·
|
Automatic and seamless to the
user. After a one-time registration, users connect
securely on a “zero-click” or “single-click”
basis.
|
|
·
|
Secure data
communications. Users create secure networks with people
they trust and communicate over a secure
channel.
|
|
·
|
Control of data at all
times. Users can secure and customize their unified
communication and collaboration applications such as file sharing and
remote desktop with policy-based access and secure presence
information.
|
|
·
|
Authenticated
users. Users know they are communicating with
authenticated users with secure domain
names.
|
|
·
|
Application-agnostic
technology. Our solution provides security at the IP
layer of the network by using patented techniques for automated DNS lookup
mechanisms to make connections between secure domain names, thereby
obviating the need to provide application specific
security.
|
|
·
|
Unique patented
technology. We are focused on developing innovative
technology for securing real-time communications over the Internet, and
establishing the exclusive secure domain name registry in the United
States and other key markets around the world. Our unique solutions
combine industry standard encryption methods and communication protocols
with our patented techniques for automated DNS lookup mechanisms. Our
technology and patented approach enables users to create a secure
communication link by generating secure domain names. We have a strong
portfolio comprised of 11 patents in the United States and eight
international patents, as well as several pending U.S. and foreign
patent applications. Our portfolio includes patents and pending patent
applications in the United States and other key markets that support our
secure domain name registry service for the
Internet.
|
|
·
|
Scalable licensing business
model. Our intellectual property portfolio is the
foundation of our business model. We are actively engaged in
commercializing our intellectual property portfolio by pursuing licensing
agreements with OEMs, service providers and system integrators within the
IP-telephony, mobility, fixed-mobile convergence and unified
communications end-markets. We have engaged ipCapital Group to accelerate
our patent and technology licensing program with customers and to expand
the depth of our intellectual property portfolio, and we are actively
pursuing our first licensing agreements. We believe that our licensing
business model is highly scalable and has the potential to generate strong
margins once we achieve significant revenue
growth.
|
|
·
|
Highly experienced research and
development team. Our
research and development team is comprised of nationally recognized
network security and encryption technology scientists and experts that
have worked together as a team for over ten years and, collectively, have
over 120 years of experience in the field. During their careers, this
team has developed several cutting-edge technologies for
U.S. national defense, intelligence and civilian agencies, many of
which remain critical to our national security today. Prior to joining
VirnetX, our team worked for SAIC during which time they invented the
technology that is the foundation of our patent portfolio, technology, and
software. Based on the collective knowledge and experience of our
development team, we believe that we have one of the most experienced and
sophisticated groups of security experts researching vulnerability and
threats to real-time communication over the Internet and developing
solutions to mitigate these
problems.
|
|
·
|
Implement
a patent and technology licensing program to commercialize our
intellectual property, including our GABRIEL Connection Technologytm.
|
|
·
|
Establish
VirnetX as the exclusive universal registry of secure domain names and to
enable our customers to act as registrars for their users and broker
secure communication between users on different
registries.
|
|
·
|
Leverage
our patent portfolio, technology and software to develop a suite of
products that can be sold directly to end-user
enterprises.
|
|
Nine Months
Ended
September 30,
2009
|
Nine Months
Ended
September 30,
2008
|
Year Ended
December 31,
2008
|
Year Ended
December 31,
2007
|
Year Ended
December 31,
2006
|
|||||||||||||||
Revenue:
|
$ | 13,594 | $ | 107,955 | $ | 133,744 | $ | 74,866 | $ | — | ||||||||||
Total operating expenses:
|
9,971,285 | 9,253,611 | 12,355,332 | 8,725,210 | 1,407,675 | |||||||||||||||
Total other income (expenses), net:
|
4,832 | 142,454 | 149,408 | (41,820 | ) | 6,336 | ||||||||||||||
Net loss:
|
$ | (9,952,859 | ) | $ | (9,003,202 | ) | $ | (12,072,180 | ) | $ | (8,692,164 | ) | $ | (1,401,339 | ) |
As of
September 30,
2009
|
As of
December 31,
2008
|
As of
December 31,
2007
|
As of
December 31,
2006
|
|||||||||||||
Cash and cash equivalents:
|
$ | 4,016,248 | $ | 457,155 | $ | 8,589,447 | $ | 139,997 | ||||||||
Total assets:
|
4,298,250 | 978,982 | 9,279,166 | 195,123 | ||||||||||||
Accounts payable and accrued
expenses:
|
4,203,919 | 1,669,333 | 531,790 | 87,386 | ||||||||||||
Total stockholders’ equity
(deficit):
|
$ | (65,669 | ) | $ | (894,351 | ) | $ | 8,495,376 | $ | 107,737 |
|
·
|
our
lawsuit against Microsoft;
|
|
·
|
infrastructure;
|
|
·
|
sales
and marketing;
|
|
·
|
research
and development;
|
|
·
|
personnel;
and
|
|
·
|
general
business enhancements.
|
|
·
|
our
capital resources may be
insufficient;
|
|
·
|
our
management team may not have sufficient bandwidth to successfully
capitalize on all of the opportunities identified by ipCapital
Group;
|
|
·
|
we
may not be successful in entering into licensing relationships with our
targeted customers on commercially acceptable terms;
and
|
|
·
|
the
validity of our patents underlying the licensing opportunity is currently
being challenged in our litigation against
Microsoft.
|
|
·
|
unwillingness
of consumers to shift to VoIP and use other such next-generation
Internet-based applications;
|
|
·
|
refusal
to purchase security products to secure information transmitted through
such applications;
|
|
·
|
perception
by the licensees of unsecure communication and data
transfer;
|
|
·
|
lack
of concern for privacy by licensees and
users;
|
|
·
|
limitations
on access and ease of use;
|
|
·
|
congestion
leading to delayed or extended response
times;
|
|
·
|
inadequate
development of Internet infrastructure to keep pace with increased levels
of use; and
|
·
|
increased
government
regulations.
|
|
·
|
the
need to educate potential customers about our patent rights and our
product and service capabilities;
|
|
·
|
customers’
willingness to invest potentially substantial resources and modify their
network infrastructures to take advantage of our
products;
|
|
·
|
customers’
budgetary constraints;
|
|
·
|
the
timing of customers’ budget cycles;
and
|
|
·
|
delays
caused by customers’ internal review
processes.
|
|
·
|
design,
develop, launch and/or license our planned products, services and
technologies that address the increasingly sophisticated and varied needs
of our prospective customers; and
|
|
·
|
respond
to technological advances and emerging industry standards and practices on
a cost-effective and timely
basis.
|
|
·
|
the
price of our products relative to other products that seek to secure
real-time communication;
|
|
·
|
the
perception by users of the effectiveness of our
products;
|
|
·
|
our
ability to fund our sales and marketing efforts;
and
|
|
·
|
the
effectiveness of our sales and marketing
efforts.
|
|
·
|
power
loss, transmission cable cuts and other telecommunications
failures;
|
|
·
|
damage
or interruption caused by fire, earthquake, and other natural
disasters;
|
|
·
|
computer
viruses or software defects; and
|
|
·
|
physical
or electronic break-ins, sabotage, intentional acts of vandalism,
terrorist attacks and other events beyond our
control.
|
|
·
|
substantially
greater financial, technical and marketing
resources;
|
|
·
|
a
larger customer base;
|
|
·
|
better
name recognition; and
|
|
·
|
more
expansive product offerings.
|
|
·
|
our
applications for patents, trademarks and copyrights relating to our
business may not be granted and, if granted, may be challenged or
invalidated;
|
|
·
|
issued
trademarks, copyrights, or patents may not provide us with any competitive
advantages;
|
|
·
|
our
efforts to protect our intellectual property rights may not be effective
in preventing misappropriation of our technology;
or
|
|
·
|
our
efforts may not prevent the development and design by others of products
or technologies similar to or competitive with, or superior to those we
develop.
|
|
·
|
the
need for continued development of the financial and information management
systems;
|
|
·
|
the
need to manage relationships with future licensees, resellers,
distributors and strategic
partners;
|
|
·
|
the
need to hire and retain skilled management, technical and other personnel
necessary to support and manage our business;
and
|
|
·
|
the
need to train and manage our employee
base.
|
|
·
|
challenges
caused by distance, language and cultural
differences;
|
|
·
|
legal,
legislative and regulatory
restrictions;
|
|
·
|
currency
exchange rate fluctuations;
|
|
·
|
economic
instability;
|
|
·
|
longer
payment cycles in some countries;
|
|
·
|
credit
risk and higher levels of payment
fraud;
|
|
·
|
potentially
adverse tax consequences; and
|
|
·
|
other
higher costs associated with doing business
internationally.
|
|
·
|
developments
in our litigation against
Microsoft;
|
|
·
|
large
purchases or sales of common stock;
|
|
·
|
actual
or anticipated announcements of new products or services by us or our
competitors;
|
|
·
|
general
conditions in the markets in which we compete;
and
|
|
·
|
general
economic and financial
conditions.
|
|
·
|
A staggered Board of
Directors: This means that only one or two directors
(since we have a five-person Board of Directors) will be up for election
at any given annual meeting. This has the effect of delaying
the ability of stockholders to effect a change in control of us since it
would take two annual meetings to effectively replace at least three
directors which represents a majority of the Board of
Directors.
|
|
·
|
Blank check preferred
stock: Our Board of Directors has the authority to
establish the rights, preferences and privileges of our
10,000,000 authorized, but unissued, shares of preferred
stock. Therefore, this stock may be issued at the discretion of
our Board of Directors with preferences over your shares of our common
stock in a manner that is materially dilutive to existing
stockholders. In addition, blank check preferred stock can be
used to create a “poison pill” which is designed to deter a hostile bidder
from buying a controlling interest in our stock without the approval of
our Board of Directors. We have not adopted such a “poison
pill;” but our Board of Directors has the ability to do so in the future,
very rapidly and without stockholder
approval.
|
|
·
|
Advance notice requirements for
director nominations and for new business to be brought up at stockholder
meetings: Stockholders wishing to submit director
nominations or raise matters to a vote of the stockholders must provide
notice to us within very specific date windows and in very specific form
in order to have the matter voted on at a stockholder
meeting. This has the effect of giving our Board of Directors
and management more time to react to stockholder proposals generally and
could also have the effect of disregarding a stockholder proposal or
deferring it to a subsequent meeting to the extent such proposal is not
raised properly.
|
|
·
|
No stockholder actions by
written consent: No stockholder or group of stockholders
may take actions rapidly and without prior notice to our Board of
Directors and management or to the minority stockholders. Along
with the advance notice requirements described above, this provision also
gives our Board of Directors and management more time to react to proposed
stockholder actions.
|
|
·
|
Super majority requirement for
stockholder amendments to the Bylaws: Stockholder
proposals to alter or amend our Bylaws or to adopt new Bylaws can only be
approved by the affirmative vote of at least 66 2/3% of the
outstanding shares.
|
|
·
|
Elimination of the ability of
stockholders to call a special meeting of the
stockholders: Only the Board of Directors or management
can call special meetings of the stockholders. This could mean
that stockholders, even those who represent a significant block of our
shares, may need to wait for the annual meeting before nominating
directors or raising other business proposals to be voted on by the
stockholders.
|
For the Nine Months ended September 30,
2009
|
For the Nine Months ended September 30,
2008
|
For the year ended December 31,
2008
|
For the year ended December 31,
2007
|
For the year ended December 31,
2006
|
Period From August 5, 2005 (Date of Inception) to
December 31, 2005
|
|||||||||||||||||||
(amounts in thousands except per
share)
|
||||||||||||||||||||||||
Consolidated Statement of Operations
Data:
|
||||||||||||||||||||||||
Revenue
|
$ | 13,594 | $ | 107,955 | $ | 133,744 | $ | 74,866 | $ | 0 | $ | 0 | ||||||||||||
Operating
expenses
|
9,971,285 | 9,253,611 | 12,355,332 | 8,725,210 | 1,407,675 | 882,478 | ||||||||||||||||||
Net
loss
|
(9,952,859 | ) | (9,003,202 | ) | (12,072,180 | ) | (8,692,164 | ) | (1,401,339 | ) | (882,478 | ) | ||||||||||||
Loss per
share
|
$ | (.27 | ) | $ | (.26 | ) | $ | (.35 | ) | $ | (.36 | ) | (.08 | ) | $ | (.06 | ) | |||||||
Consolidated Balance Sheet Data
|
||||||||||||||||||||||||
Cash and cash equivalents
|
$ | 4,016,248 | $ | 2,260,170 | $ | 457,155 | $ | 8,589,447 | $ | 139,997 | $ | 86,552 | ||||||||||||
Total
assets
|
4,298,250 | 3,079,152 | 978,982 | 9,279,166 | 195,123 | 147,722 | ||||||||||||||||||
Long-term
obligation
|
120,000 | 160,000 | 160,000 | 204,000 | 0 | 0 | ||||||||||||||||||
Stockholders ’ equity (deficit)
|
$ | (65,669 | ) | $ | 1,407,740 | $ | (894,351 | ) | $ | 8,495,376 | $ | 107,737 | $ | (82,278 | ) |
First
|
Second
|
Third
|
Fourth
|
|||||||||||||
(amounts in thousands except per
share)
|
||||||||||||||||
2009
|
||||||||||||||||
Revenue
|
$ | 3 | $ | 7 | $ | 3 | N/A | |||||||||
Loss from operations
|
(3,405 | ) | (3,928 | ) | (2,624 | ) | N/A | |||||||||
Net loss
|
(3,403 | ) | (3,927 | ) | (2,623 | ) | N/A | |||||||||
Net loss per common share
|
$ | (0.09 | ) | $ | (0.11 | ) | $ | (0.07 | ) | N/A | ||||||
2008
|
||||||||||||||||
Revenue
|
$ | 33 | $ | 51 | $ | 24 | $ | 26 | ||||||||
Loss from operations
|
(3,102 | ) | (3,096 | ) | (2,947 | ) | (3,077 | ) | ||||||||
Net loss
|
(3,032 | ) | (3,049 | ) | (2,923 | ) | (3,068 | ) | ||||||||
Net loss per common share
|
$ | (0.09 | ) | $ | (0.09 | ) | $ | (0.08 | ) | $ | (0.08 | ) | ||||
2007
|
||||||||||||||||
Revenue
|
$ | 0 | $ | 0 | $ | 47 | $ | 28 | ||||||||
Loss from operations
|
(766 | ) | (1,233 | ) | (2,589 | ) | (4,137 | ) | ||||||||
Net loss
|
(781 | ) | (1,231 | ) | (2,566 | ) | (4,114 | ) | ||||||||
Net loss per common share
|
$ | (0.04 | ) | $ | (0.07 | ) | $ | (0.08 | ) | $ | (0.15 | ) |
·
|
our lawsuit against
Microsoft;
|
·
|
infrastructure;
|
·
|
sales and
marketing;
|
·
|
research and
development;
|
·
|
personnel;
and
|
·
|
general business
enhancements.
|
For the
Year
|
Minimum Required Lease Payments in Period
|
|||
2009
|
$ | 44,373 | ||
2010
|
54,595 | |||
2011
|
59,242 | |||
2012
|
30,202 | |||
$ | 188,412 |
Options Outstanding
|
||||||||||||
Shares Available for Grant
|
Number of Shares
|
Weighted Average Exercise
Price
|
||||||||||
Shares reserved for the Plan at
inception
|
11,624,469 | — | — | |||||||||
Restricted stock units granted
|
(3,321,277 | ) | — | — | ||||||||
Options granted
|
— | — | — | |||||||||
Options exercised
|
— | — | — | |||||||||
Options cancelled
|
— | — | — | |||||||||
Balance at December 31, 2005
|
8,303,192 | — | — | |||||||||
Restricted stock units granted
|
(1,058,657 | ) | — | — | ||||||||
Options granted
|
(1,868,218 | ) | 1,868,218 | $ | .24 | |||||||
Options exercised
|
— | — | — | |||||||||
Options cancelled
|
— | — | — | |||||||||
Balance at December 31, 2006
|
5,376,317 | 1,868,218 | $ | . 24 | ||||||||
Restricted stock units granted
|
— | — | — | |||||||||
Options granted
|
(2,324,925 | ) | 2,324,925 | 4.96 | ||||||||
Options exercised
|
(124,548 | ) | .24 | |||||||||
Options cancelled
|
— | — | — | |||||||||
Balance at December 31, 2007
|
3,051,392 | 4,068,595 | $ | 2.94 | ||||||||
Restricted stock units granted
|
— | — | — | |||||||||
Options granted
|
(420,000 | ) | 420,000 | 3.42 | ||||||||
Options exercised
|
— | — | — | |||||||||
Options cancelled
|
20,000 | (20,000 | ) | 4.20 | ||||||||
Balance at December 31, 2008
|
2,651,392 | 4,468,595 | $ | 2.98 |
·
|
Automatic
and seamless to the user . After a one-time registration, users connect
securely on a “zero-click” or “single-click”
basis.
|
·
|
Secure
data communications . Users
create secure networks with people they trust and communicate over a
secure channel.
|
·
|
Control of
data at all times . Users can
secure and customize their unified communication and collaboration
applications such as file sharing and remote desktop with policy-based
access and secure presence
information.
|
·
|
Authenticated
users . Users know they are
communicating with authenticated users with secure domain
names.
|
·
|
Application-agnostic
technology . Our solution
provides security at the IP layer of the network by using patented DNS
lookup mechanisms to make connections between secure domain names, thereby
obviating the need to provide application specific
security.
|
·
|
Unique
patented technology . We are
focused on developing innovative technology for securing real-time
communications over the Internet, and establishing the exclusive secure
domain name registry in the United States and other key markets
around the world. Our unique solutions combine industry
standard encryption methods and communication protocols with our patented
techniques for automated DNS lookup mechanisms. Our technology
and patented approach enables users to create a secure communication link
by generating secure domain names. We have a strong portfolio
comprised of 12 patents in the United States and eight international
patents, as well as several pending U.S. and foreign patent
applications. Our portfolio includes patents and pending patent
applications in the United States and other key markets that support our
secure domain name registry service for the
Internet.
|
·
|
Scalable
licensing business model . Our intellectual property portfolio is the
foundation of our business model. We are actively engaged in
commercializing our intellectual property portfolio by pursuing licensing
agreements with OEMs, service providers and system integrators within the
IP-telephony, mobility, fixed-mobile convergence and unified
communications end-markets. We have engaged ipCapital Group to
accelerate our patent and technology licensing program with customers and
to expand the depth of our intellectual property portfolio, and we are
actively pursuing our first licensing agreements. We believe
that our licensing business model is highly scalable and has the potential
to generate strong margins once we achieve significant revenue
growth.
|
·
|
Highly
experienced research and development team . Our research and development team is comprised
of nationally recognized network security and encryption technology
scientists and experts that have worked together as a team for over ten
years and, collectively, have over 120 years of experience in the
field. During their careers, this team has developed several
cutting-edge technologies for U.S. national defense, intelligence and
civilian agencies, many of which remain critical to our national security
today. Prior to joining VirnetX, our team worked for SAIC
during which time they invented the technology that is the foundation of
our patent portfolio, technology, and software. Based on the
collective knowledge and experience of our development team, we believe
that we have one of the most experienced and sophisticated groups of
security experts researching vulnerability and threats to real-time
communication over the Internet and developing solutions to mitigate these
problems.
|
·
|
Implement a patent and technology licensing program to
commercialize our intellectual property, including our GABRIEL Connection
Technology TM .
|
·
|
Establish VirnetX as the exclusive universal registry of
secure domain names and to enable our customers to act as registrars for
their users and broker secure communication between users on different
registries.
|
·
|
Leverage our existing patent portfolio and technology to
develop a suite of products that can be sold directly to end-user
enterprises.
|
·
|
VirnetX
patent licensing : Customers
who want to develop their own implementation of the VirnetX code module
for supporting secure domain names, or who want to use their own
techniques that are covered by our patent portfolio for establishing
secure communication links, will purchase a patent license. The
number of patents licensed, and therefore the cost of the patent license
to the customer, will depend upon which of the patents are used in a
particular product or service. These licenses will typically
include an initial license fee, as well as an ongoing
royalty.
|
·
|
GABRIEL
Connection Technology TM Software
Development Kit, or SDK : OEM
customers who want to adopt the GABRIEL Connection Technology TM as their solution for establishing secure connections
using secure domain names within their products will purchase an SDK
license. The software development kit consists of object
libraries, sample code, testing and quality assurance tools and the
supporting documentation necessary for a customer to implement our
technology. These tools are comprised of software for a secure
domain name connection test server, a relay test server and a registration
test server. Customers will pay an up-front license fee to purchase an SDK
license and a royalty fee for every product shipped with the embedded
VirnetX code module.
|
·
|
Secure
domain name registrar service : Customers, including service providers,
telecommunication companies, ISPs, system integrators and OEMs can
purchase a license to our secure domain name registrar
service. We provide the software suite and technology support
to enable such customers to provision devices with secure domain names and
facilitate secure connections between registered devices. This
suite includes the following server software
modules:
|
·
|
Registrar
server software : Enables
customers to operate as a secure domain name registrar that provisions
devices with secure domain names. The registrar server software
provides an interface for our customers to register new virtual private
domains and sub-domain names. This server module must be
enrolled with the VirnetX secure domain name master registry to obtain its
credentials before functioning as an authorized
registrar.
|
·
|
Connection
server software : Allows
customers to provide connection services to enrolled
devices. The connection services include registration of
presence information for authenticated users and devices, presence
information query request services, enforcement of policies and support
for communication with peers behind
firewalls.
|
·
|
Relay
server software : Allows
customers to dynamically maintain connections and relay data to private IP
addresses for network devices that reside behind
firewalls.
|
·
|
Secure
domain name master registry and connection service : As part of enabling the secure domain name
registrar service, we will maintain and manage the secure domain name
master registry. This service will enroll all secure domain
name registrar customers and generate the credentials required to function
as an authorized registrar. It also provides connection
services and universal name resolution, presence information and secure
connections between authorized devices with secure domain
names.
|
·
|
Technical
support services : We intend
to provide high-quality technical support services to licensees and
customers for the rapid customization and deployment of GABRIEL Connection
Technology TM in an individual customer’s products and
services.
|
·
|
Proprietary or home-grown application specific security
solutions have been developed by vendors and integrated directly into
their products for our target markets including IP-telephony, mobility,
fixed-mobile convergence, and unified communications. These
proprietary solutions have been developed due to the lack of standardized
approaches to securing real-time communications. This approach
has led to corporate networks that are isolated and, as a result, restrict
enterprises to using these next-generation networks within the boundaries
of their private network. These solutions generally do not
provide security for communications over the Internet or require network
administrators to manually exchange keys and other security parameters
with each destination network outside their corporate network
boundary. The cost-savings and other benefits of IP-based
real-time communications are significantly limited by this approach to
securing real-time
communications.
|
·
|
A session border controller, or SBC, is a device used in
networks to exert control over the signaling and media streams involved in
establishing, conducting and terminating VoIP calls. Signaling
protocols such as SIP and XMPP, transfer information including endpoint IP
addresses and port numbers in a manner that prevents this information from
being seen by a traditional firewall or network address translation, or
NAT, device, and reaching the intended destination. SBCs are
used in physical networks to address these limitations and enable
real-time session traffic to cross the boundaries created by firewalls and
other NAT devices and enable VoIP calls to be established
successfully. However, SBCs must decrypt and analyze every
single data packet for the information to be transmitted successfully,
thereby preventing end-to-end encryption. This network design
results in SBCs becoming a single point of congestion on the network, as
well as a single point of failure. SBCs are also limited to the
physical network they
secure.
|
·
|
SIP firewalls, or SIP-aware firewalls, and application
layer gateways, manage and protect the traffic, flow and quality of VoIP
and other SIP-related communications. They perform real-time
network address translation and dynamic firewall functions and support
multiple signaling protocols, and media functionality, allowing secure
interconnection and the flow of IP media streams across multiple
networks. While SIP firewalls assist in analyzing SIP traffic
transmitted over the corporate network to filter out various threats, they
do not necessarily encrypt the traffic. As a result, this
traffic is not entirely secure from end-to-end nor is it protected against
threats like man-in-middle and
eavesdropping.
|
U.S. Patent Number
Link to Patent
|
Title of Patent
|
6,502,135
|
Agile network protocol for secure communications with
assured system availability
|
6,618,761
|
Agile network protocol for secure communications with
assured system availability
|
6,826,616
|
Method for establishing secure communication link between
computers of virtual private network
|
6,834,310
|
Preventing packet flooding of a computer on a computer
network
|
6,839,759
|
Method for establishing secure communication link between
computers of virtual private network without user entering any
cryptographic information
|
6,907,473
|
Agile network protocol for secure communications with
assured system availability
|
7,010,604
|
Agile network protocol for secure communications with
assured system availability
|
7,133,930
|
Agile network protocol for secure communications with
assured system availability
|
7,188,180
|
Method for establishing secure communication link between
computers of virtual private network
|
7,209,479
|
Third party VPN certification
|
7,418,504
|
Agile network protocol for secure communications using
secure domain names
|
7,490,151
|
Establishment of a secure communication link based on a
domain name service (DNS)
request
|
·
|
Patent
assignment . SAIC
unconditionally and irrevocably conveyed, transferred, assigned and
quitclaimed all its right, title and interest in and to the patents and
patent applications, as specifically set forth on Exhibit A to the
assignment document recorded with the U.S. Patent and Trademark
Office, including, without limitation, the right to sue for past
infringement.
|
·
|
License to
SAIC outside the field of use . On November 2, 2006, we granted to SAIC
an exclusive, royalty free, fully paid, perpetual, worldwide, irrevocable,
sublicensable and transferable right and license permitting SAIC and its
assignees to make, have made, import, use, offer for sale, and sell
products and services covered by, and to make improvements to, the patents
and patent applications we acquired from SAIC, solely outside our field of
use. We have, and retain, all right, title and interest to all
our patents within our field of use. Our field of use is
defined as the field of secure communications in the following
areas: virtual private networks, or VPNs; secure VoIP;
electronic mail, or e-mail; video conferencing; communications logging;
dynamic uniform resource locators, or URLs; denial of service; prevention
of functional intrusions; IP hopping; voice messaging and unified
messaging; live voice and IP PBXs; voice web video conferencing and
collaboration; IM; minimized impact of viruses; and secure session
initiation protocol or SIP. Our field of use is not limited by
any predefined transport mode or medium of communication (for example,
wire, fiber, wireless, or mixed medium). On March 12,
2008, SAIC relinquished the November 2, 2006, exclusive grant back
license outside our field of use, as well as any right to obtain such
exclusive license in the future. Effective March 12, 2008,
we granted to SAIC a non-exclusive, royalty free, fully paid, perpetual,
worldwide, irrevocable, sublicensable and transferable right and license
permitting SAIC and its assignees to make, have made, import, use, offer
for sale, and sell products and services covered by, and to make
improvements to, the patents and patent applications we acquired from
SAIC, solely outside our field of
use.
|
·
|
Compensation
obligations . As
consideration for the assignment of the patents and for the rights we
obtained from SAIC as a result of the March 12, 2008 amendment, we
are required to make payments to SAIC based on the revenue generated from
our ownership or use of the patents assigned to us by
SAIC.
|
·
|
Our compensation obligation includes payment of royalties,
in an amount equal to (a) 15% of all gross revenues generated by us
in our field of use less (1) trade, quantity and cash discounts
allowed, (2) commercially reasonable commissions, discounts, refunds,
rebates, chargebacks, retroactive price adjustments and other allowances
which effectively reduce the net selling price, and which are based on
arms length terms and are customary and standard in VirnetX’s industry,
and (3) actual product returns and allowances; (b) 15% of all
non-license gross revenues generated by us outside our field of use less
(1) trade, quantity and cash discounts allowed, (2) commercially
reasonable commissions, discounts, refunds, rebates, chargebacks,
retroactive price adjustments and other allowances which effectively
reduce the net selling price, and which are based on arms length terms and
are customary and standard in VirnetX’s industry, and (3) actual
product returns and allowances; and (c) 50% of all license revenues
generated by us outside our field of use less (1) trade, quantity and
cash discounts allowed, (2) commercially reasonable commissions,
discounts, refunds, rebates, chargebacks, retroactive price adjustments
and other allowances which effectively reduce the net selling price, and
which are based on arms length terms and are customary and standard in
VirnetX’s industry, and (3) actual product returns and
allowances.
|
·
|
Royalty payments are calculated based on each quarter and
payment is due within 30 days following the end of each
quarter.
|
·
|
Beginning 18 months after January 1, 2007, we
must make a minimum guaranteed annual royalty payment of
$50,000.
|
·
|
The maximum cumulative royalty paid in respect to our
revenue-generating activities in our field of use shall be no more than
$35 million.
|
·
|
In addition to the royalties, in the circumstances and
subject to the limitations specified in the November amendment, SAIC shall
be entitled to receive 10% of any proceeds, revenues, monies or any other
form of consideration paid for the acquisition of VirnetX by Microsoft or
any other party alleged to be infringing the patents or patent
applications we acquired from SAIC, up to a maximum amount of
$35 million. Any such payments to SAIC shall be credited
against the $35 million maximum cumulative royalty payable with
respect to our revenue-generating activities in our field of
use.
|
·
|
In the event that VirnetX receives any proceeds, recovery
or other form of compensation (other than acquisition proceeds) as a
result of any action or proceeding brought by VirnetX against Microsoft or
certain other alleged infringing companies to resolve a claim of
infringement or enforcement relating to the patents and patent
applications we acquired from SAIC, or as a result of negotiations with
such entities, as further consideration for the assignment of the patents,
in lieu of any amounts otherwise owing to SAIC we must pay to SAIC 35% of
the excess of such proceeds over all costs incurred in connection with any
such litigation, without a cap. Any payment to SAIC of amounts
with respect to such proceeds shall be credited against the
$35 million maximum cumulative royalty payable with respect to our
revenue-generating activities in our field of
use.
|
·
|
In the event that VirnetX receives any proceeds, recovery
or other form of compensation as a result of any action or proceeding
brought by VirnetX against parties other than Microsoft and certain other
alleged infringing companies, with respect to which VirnetX is required to
notify SAIC of infringement under the terms of the November amendment to
resolve a claim of infringement or enforcement relating to the patents and
patent applications we acquired from SAIC, or as a result of negotiations
with such entities (other than acquisition proceeds) as further
consideration for the assignment of the patents, in lieu of any amounts
otherwise owing to SAIC we must pay to SAIC 25% of the excess of such
proceeds over all costs incurred in connection with any such litigation,
without a cap. Any payment to SAIC of amounts with respect to
such proceeds shall be credited against the $35 million maximum
cumulative royalty payable with respect to our revenue-generating
activities in our field of
use.
|
·
|
Reversion
to SAIC upon breach or default . We must convey, transfer, assign and quitclaim
to SAIC all of our right, title and interest in and to the patents or
patent applications we acquired from SAIC, upon the first occurrence of
the following reversion
events:
|
·
|
our failure to pay SAIC an aggregate cumulative amount of
at least $7.5 million within seven years after January 1,
2007;
|
·
|
our failure to pay the $50,000 minimum annual royalty that
has not been cured within 90 days after our receipt of written notice
of such failure; or
|
·
|
for the period prior to the date of our full payment of the
$35 million maximum cumulative royalty, any termination of the August
2005 agreement with SAIC, as
amended.
|
·
|
Rights to
bring and control actions for infringement and
enforcement . In addition to
the exclusive right to bring and control any action or proceeding with
respect to infringement or enforcement of our patents, and to collect
damages and fees for past, present and future infringement, both in and
outside of our field of use, we also have the first right to negotiate
with or bring a lawsuit against any and all third parties for purposes of
enforcing our patents, regardless of the field of
use.
|
·
|
Security
agreement . We granted SAIC a
security interest in some of our intellectual property, including the
patents and patent applications we obtained from SAIC, to secure our
payment obligations to SAIC described
above.
|
Name
|
Age
|
Position
|
Kendall Larsen
|
52
|
President, Chief Executive Officer and
Director
|
William E. Sliney
|
71
|
Chief Financial Officer (Interim)
|
Edmund C. Munger
|
65
|
Director
|
Scott C. Taylor
|
45
|
Director
|
Michael F. Angelo
|
50
|
Director
|
Thomas M. O’Brien
|
43
|
Director
|
|
·
|
Early and late stage private
companies using a semi-annual survey of private, venture-backed companies
that have received at least one round of financing from a professional
U.S.-based venture capital firm. Of the companies in this survey, over
one-half are in the information technology business and the remainder are
divided between healthcare, products and services and other
companies.
|
|
·
|
A key comparable company,
Medivation, Inc., which also completed a reverse merger followed by an
underwritten direct primary public offering. This company had similar
market capitalization compared to us and was similarly early stage and
pre-revenue at the time of their reverse merger, although this company is
a medical device
company.
|
|
·
|
Public company peers using data
we gathered from the SEC filings of ten public companies with the same
industry code as us and otherwise in a comparable industry, having a
market capitalization of between $25 million and $500 million,
and in a similar geographic
region.
|
|
·
|
attracting and retaining the most
talented and dedicated executives
possible;
|
|
·
|
correlating annual and long-term
cash and stock incentives to achievement of measurable performance
objectives; and
|
|
·
|
aligning executives’ incentives
with stockholder value
creation.
|
|
·
|
Base Salary. Base
salaries for our executives are established based on the scope of their
responsibilities, taking into account competitive market compensation paid
by other companies for similar positions. Generally, the program is
designed to deliver executive base salaries within the range of salaries
for executives with the requisite skills in similar positions with similar
responsibilities at comparable companies, in line with our compensation
philosophy. Executives with more experience, critical skills, and/or
considered key performers may be compensated above the range as part of
our strategy for attracting, motivating and retaining highly experienced
and high performing employees. Base salaries are reviewed annually and
adjusted from time to time to realign salaries with market levels after
taking into account individual responsibilities, performance, and
experience. This review generally occurs each year in the fourth quarter
and adjustments are made from time to time to ensure market
competitiveness.
|
|
·
|
Discretionary Annual Incentive
Bonus. Each year, our compensation committee establishes a target
discretionary annual incentive bonus pool based on a percentage of an
executive’s base salary and the achievement of corporate and individual
objectives. Our compensation committee may award discretionary annual
incentive bonuses to our chief executive officer or other employees. Our
compensation committee utilizes annual incentive bonuses to compensate
officers for achieving financial and operational goals and for achieving
individual annual performance objectives. These objectives vary depending
on the individual executive, but relate generally to strategic factors
such as establishment and maintenance of key strategic relationships,
development and implementation of our licensing strategy, development of
our product, identification and advancement of additional products, and to
financial factors such as raising capital, improving our results of
operations, and increasing the price per share of our common
stock.
|
|
·
|
Long-Term Incentive
Program. We believe that long-term performance is achieved through
an ownership culture that encourages high performance by our executive
officers through the use of stock and stock-based awards. Our 2007 Stock
Plan was established to provide our employees, including our executive
officers, with incentives to help align those employees’ interests with
the interests of stockholders. Our compensation committee believes that
the use of stock and stock-based awards offers the best approach to
achieving our compensation goals. We have historically elected to use
stock options as the primary long-term equity incentive
vehicle.
|
|
·
|
Stock Option Grants.
Stock option grants are made at the commencement of employment, may be
made annually based upon performance and, occasionally, following a
significant change in job responsibilities or to meet other special
retention objectives. Our compensation committee reviews and approves
stock option awards to executive officers based upon a review of
competitive compensation data, its assessment of individual performance, a
review of each executive’s existing long-term incentives, and retention
considerations. In determining the number of stock options to be granted
to executives, we take into account the individual’s position, scope of
responsibility, ability to affect profits and stockholder value, the
individual’s historic and recent performance, the value of stock options
in relation to other elements of the individual executive’s total
compensation, and the individual’s potential ownership as a percentage of
our total outstanding shares relative to comparable companies. We expect
to continue to use stock options as a long-term incentive vehicle
because:
|
|
·
|
stock
options align the interests of executives with those of the stockholders,
support a pay-for-performance culture, foster employee stock ownership,
and focus the management team on increasing value for the
stockholders;
|
|
·
|
stock
options are performance based and all the value received by the recipient
of a stock option is based on the growth of the stock
price;
|
|
·
|
stock
options help to provide a balance to the overall executive compensation
program as base salary and our discretionary annual bonus program focus on
short-term compensation, while the vesting of stock options increases
stockholder value over the longer term;
and
|
|
·
|
the
vesting period of stock options encourages executive retention and the
preservation of stockholder
value.
|
Name & Principal
|
|||||||||||||||||||||
Position
|
Year
|
Salary ($)
|
Bonus ($)
|
Option Awards ($) (1)
|
All Other
Compensation
($)(2)
|
Total ($)
|
|||||||||||||||
Kendall Larsen
|
2008
|
275,000
|
—
|
253,903
|
528,903
|
||||||||||||||||
Chief Executive Officer, President and
Director
|
2007
|
245,000
|
244,211
|
21,159
|
510,370
|
||||||||||||||||
2006
|
237,039
|
—
|
7,665
|
244,704
|
|||||||||||||||||
William E. Sliney
|
2008
|
98,442
|
—
|
470,536
|
568,978
|
||||||||||||||||
Chief Financial Officer
|
2007
|
36,460
|
15,313
|
39,211
|
90,984
|
||||||||||||||||
2006
|
30,000
|
30,000
|
(1)
|
The amounts in this column reflects amounts recognized for
financial statement reporting purposes for the stated fiscal years for
stock options granted in that fiscal year and in prior fiscal years, in
accordance with SFAS 123R. However, these amounts do not include any
reduction for risk of forfeiture related to service-based vesting. The
option awards included in this expense amount were granted from
December 31, 2007 through December 31, 2008. These amounts
reflect our accounting expense for these awards and do not represent the
actual value that may be realized by the Named Executive Officers. There
can be no assurance that these amounts will ever be realized. For
information on the valuation assumptions used in valuing stock option
awards, refer to the Note to the consolidated financial statements
contained in the Company’s Annual Report on Form 10-K for the fiscal year
in which the stock option was granted titled “Stock Based
Compensation.”
|
|
(2)
|
The amounts in this column reflect compensation earned by
the Named Executive Officer for consulting services he provided to the
Company.
|
Number of
|
||||||||||||||||||||
Securities
|
||||||||||||||||||||
Underlying
|
Number of Securities
|
|||||||||||||||||||
Unexercised
|
Underlying
|
Option
|
Option
|
|||||||||||||||||
Options
|
Unexercised Options
|
Exercise
|
Expiration
|
|||||||||||||||||
Name
|
Grant Date
|
Exercisable (#)
|
Unexercisable (#)
|
Price ($)
|
Date
|
|||||||||||||||
Kendall Larsen
|
||||||||||||||||||||
Chief Executive Officer,
|
03/23/2006
|
41,516
|
-0-
|
0.2408712
|
03/22/2016
|
|||||||||||||||
President and Director
|
12/31/2007
|
53,330
|
159,989
|
(1)
|
6.468
|
12/30/2012
|
||||||||||||||
William E. Sliney
Chief Financial Officer
|
12/31/2007
|
95,774
|
287,321
|
(1)
|
5.88
|
12/30/2017
|
(1)
|
On the first anniversary of the date of grant, 1/4th of the
shares vested and became exercisable, with 1/48th of the shares vesting
and becoming exercisable each month
thereafter.
|
|
·
|
we
have been or are to be a
participant;
|
|
·
|
the
amount involved exceeds
$120,000; and
|
|
·
|
any
of our directors, executive officers, holders of more than 5% of our
capital stock, or any immediate family member of, or person sharing the
household with, any of these individuals, had or will have a direct or
indirect material
interest.
|
|
·
|
San Gabriel
Fund, LLC
|
|
·
|
JMW
Fund, LLC
|
|
·
|
John
P. McGrain
|
|
·
|
The
John P. McGrain Grantor Retained Annuity Trust u/t/d/ June 25,
2007
|
|
·
|
John
P. McGrain, SEP IRA
|
|
·
|
John
P. McGrain, 401K
|
|
·
|
The
Westhampton Special Situations Fund,
LLC
|
|
·
|
The
Kirby Enterprise Fund, LLC
|
|
·
|
Kearney
Properties, LLC
|
|
·
|
Kearney
Holdings, LLC
|
|
·
|
Charles
F. Kirby, Roth IRA
|
|
·
|
Charles
F. Kirby
|
|
·
|
all
persons known to us, based on statements filed by such persons pursuant to
Section 13(d) or 13(g) of the Exchange Act or in statements made to us, to
be the beneficial owners of more than 5% of our common stock and based on
the records of Corporate Stock Transfer, Inc., our transfer
agent;
|
|
·
|
each
director;
|
|
·
|
each
of our Named Executive Officers in the table under “Executive Compensation
— Summary Compensation Table” on page 46 of this prospectus;
and
|
|
·
|
all
current directors and executive officers as a
group.
|
Name and Address of
Beneficial Owner
|
Amount and Nature
of Beneficial
Ownership
(1)
|
Percent
Of Class(2)
|
||
5% or Greater Stockholders:
|
||||
Gregory H. Bailey
c/o 15 Barberry Place, Suite 809
Toronto, Ontario, Canada M2K1G9(3)
|
2,328,342(3)
|
5.86%
|
||
Kendall Larsen
5615
Scotts Valley Dr., #110
Scotts
Valley, CA 95066
|
9,449,492(4)
|
23.46%
|
||
Robert M. Levande
730 Fifth Ave., 9th Floor
New York, NY 10019
|
2,084,101(5)
|
5.24%
|
||
Directors and Executive Officers:
|
||||
Kendall Larsen
|
9,449,492(4)
|
23.46%
|
||
Edmund C. Munger
|
1,034,762(6)
|
2.54%
|
||
William E. Sliney
|
196,713(7)
|
*
|
||
Thomas M. O’Brien
|
161,664(8)
|
*
|
||
Michael F. Angelo
|
86,516(9)
|
*
|
||
Scott C. Taylor
|
45,000(10)
|
*
|
||
All directors and executive officers as a group (6
persons):
|
10,974,147
(4)(6)(7)(8)
(9) (10)
|
26.43%
|
||
(1)
|
Beneficial ownership is determined in accordance with the
rules of the SEC and generally includes voting or investment power with
respect to securities. Shares of common stock subject to options and
warrants which are exercisable or convertible at or within 60 days of
November 30, 2009 are deemed outstanding for computing the percentage of
the person holding such option or warrant but are not deemed outstanding
for computing the percentage of any other person. The indication herein
that shares are beneficially owned is not an admission on the part of the
listed stockholder that he, she or it is or will be a direct or indirect
beneficial owner of those
shares.
|
(2)
|
Based upon 39,750,927 shares of common stock issued and
outstanding on November 30,
2009.
|
(3)
|
Consists of (i) 2,260,075 shares directly held by Gregory
H. Bailey, and (ii) 68,267 shares held by Palantir Group, Inc., of which
Mr. Bailey has voting and investment
power.
|
(4)
|
Consists of (i) 532,198 shares issuable pursuant to options
exercisable as follows: 148,175 options held by Mr. Larsen and 384,023
options held by Mrs. Larsen; (ii) 608,530 shares held by Mrs. Larsen;
(iii) 5,572 shares held in brokerage accounts by Mrs. Larsen’s two adult
children (the “Sheehan Children”); (iv) 100,000 shares held in
irrevocable trusts for the benefit of the Sheehan Children and (v) 50,000
shares held in an irrevocable trust for the benefit of Mr. Larsen’s
son. Mr. Larsen disclaims beneficial ownership of the 764,102
shares held by Mrs. Larsen, the Sheehan Children and his
son.
|
(5)
|
Consists of (i) 1,876,521 shares directly held by Robert M.
Levande and (ii) 207,580 shares held by the Arthur Brown Trust FBO Carolyn
Brown Levande, of which Mr. Levande has voting and investment
power.
|
(6)
|
Includes (i) 908,161 shares issuable pursuant to vested
options and (ii) 35,001 shares issuable pursuant to
warrants.
|
(7)
|
Includes (i) 191,547 shares issuable pursuant to vested
options and (ii) 3,000 shares issuable pursuant to
warrants.
|
(8)
|
Includes (i) 45,000 shares issuable pursuant to vested
options and (ii) 69,999 shares issuable pursuant to
warrants.
|
(9)
|
Includes 45,000 shares issuable pursuant to vested
options.
|
(10)
|
Shares issuable pursuant to vested
options.
|
(*)
|
Less than
1% .
|
|
·
|
providing
general oversight of the
business;
|
|
·
|
approving
corporate strategy;
|
|
·
|
approving
major management
initiatives;
|
|
·
|
providing
oversight of legal and ethical
conduct;
|
|
·
|
overseeing
our management of significant business
risks;
|
|
·
|
selecting,
compensating, and evaluating
directors;
|
|
·
|
evaluating
Board processes and
performance; and
|
|
·
|
reviewing
and implementing recommendations and reports of the compensation committee
on our compensation
practices.
|
|
·
|
no
director qualifies as “independent” if such person has a relationship
which, in the determination of at least a majority of the Board, would
interfere with exercise of independent judgment in carrying out the
responsibilities of a
director;
|
|
·
|
a
director who is an officer or employee of us or our subsidiaries, or one
whose immediate family member is an executive officer of us or our
subsidiaries, is not “independent” until three years after the end of such
employment
relationship;
|
|
·
|
a
director who accepts, or whose immediate family member accepts, more than
$100,000 in compensation from us or any of our subsidiaries during any
period of 12 consecutive months within the three years preceding the
determination of independence, other than certain permitted payments such
as compensation for Board or Board committee service, payments arising
solely from investments in our securities, compensation paid to a family
member who is a non-executive employee of us or a subsidiary of ours, or
benefits under a tax-qualified retirement plan is not considered
“independent”;
|
|
·
|
a
director who is, or who has a family member who is, a partner in, or a
controlling stockholder or an executive officer of, any organization to
which we made, or from which we received, payments for property or
services that exceed 5% of the recipient’s consolidated gross revenues for
that year, or $200,000, whichever is more, is not “independent” until
three years after falling below such
threshold;
|
|
·
|
a
director who is employed, or one whose immediate family member is
employed, as an executive officer of another company where any of our, or
any of our subsidiaries’, present executives serve on that company’s
compensation committee is not “independent” until three years after the
end of such service or employment
relationship; and
|
|
·
|
a
director who is, or who has a family member who is, a current partner of
our independent registered public accounting firm, Farber Hass Hurley LLP,
or was a partner or employee of Farber Hass Hurley LLP who worked on our
audit is not “independent” until three years after the end of such
affiliation or employment
relationship.
|
Director
|
Nominating
and
Corporate
Governance
Committee
|
Compensation
Committee
|
Audit
Committee
|
|||
Michael F. Angelo
|
Chair
|
X
|
X
|
|||
Kendall Larsen
|
||||||
Edmund C. Munger
|
||||||
Thomas M. O’Brien
|
X
|
X
|
Chair
|
|||
Scott C. Taylor
|
X
|
Chair
|
X
|
|
·
|
assisting
our Board in identifying prospective director nominees and recommending to
the Board director nominees for each annual meeting of stockholders,
vacancy or newly created director
position;
|
|
·
|
developing
and recommending to our Board governance principles applicable to us,
including the Code of
Ethics;
|
|
·
|
overseeing
the evaluation of our Board and
management; and
|
|
·
|
delegating
such of its authority and responsibilities as it deems proper to members
of the committee or a
subcommittee.
|
|
·
|
appointment
of and approval of compensation for our independent public accounting
firm, including oversight of its
independence;
|
|
·
|
oversight
of our accounting and financial reporting
processes;
|
|
·
|
oversight
of the audits of our financial
statements;
|
|
·
|
oversight
of the effectiveness of our internal control over financial
reporting; and
|
|
·
|
preparing
the audit committee report that the SEC requires in our annual proxy
statement.
|
|
·
|
exclusive
authority for determining our chief executive officer’s
compensation;
|
|
·
|
determining
for other executive officers: annual base salary, annual incentive bonus,
including the specific goals and amount, equity compensation, employment
agreements, severance arrangements and change in control
agreements/provisions, and any other benefits or compensation arrangement,
including delegating its authority on these matters with regard to our
non-officer employees and consultants to appropriate supervisory
personnel;
|
|
·
|
evaluating
and recommending to our Board compensation plans, policies, and programs
for our chief executive officer and other executive
officers;
|
|
·
|
administering
our equity incentive
plans; and
|
|
·
|
preparing
the compensation committee report that the SEC requires in our annual
proxy statement.
|
|
·
|
Meetings. Our
compensation committee acted by written consent one time during the fiscal
year ended December 31,
2008; and
|
|
·
|
Role of executive
officers. Our president and chief executive officer
generally attends compensation committee meetings and sometimes makes
recommendations to our compensation committee regarding the amount and
form of the compensation of the other executive officers and key
employees. He is not present for any of the executive sessions or for any
discussion of his own
compensation.
|
|
·
|
each non-employee director will
receive a quarterly cash retainer of
$5,000;
|
|
·
|
each non-employee director who
serves as a member of our audit committee will receive a quarterly cash
retainer of $625; each non-employee director who serves as a member of our
compensation or nominating and corporate governance committees will
receive a quarterly cash retainer of $500 for each
committee;
|
|
·
|
each non-employee director who
serves as a chair of our audit committee will receive a quarterly cash
retainer of $3,125; each non-employee director who serves as a chair of
our compensation or nominating and corporate governance committees will
receive a quarterly cash retainer of $1,250;
and
|
|
·
|
each non-employee director who
attends a board meeting will receive a cash payment of $1,500 ($500 for
telephone participation) and each non-employee director who attends a
committee meeting will receive a cash payment of $1,000 ($500 for
telephone
participation).
|
|
·
|
each new non-employee director
will be granted an option to purchase 30,000 shares of common stock with a
per-share exercise price equal to the fair market value of that stock on
the date of grant and which will vest monthly with respect to 1/36th of
the total number of shares subject to the option, conditioned upon
continued service as a director; provided that these options automatically
become exercisable in full immediately prior to a “Change of Control” as
defined in the 2007 Stock Plan;
and
|
|
·
|
each existing non-employee
director will be granted an option to purchase 10,000 shares of common
stock with a per-share exercise price equal to the fair market value of
that stock on the date of grant and which will be fully vested on the date
of grant.
|
Fees Earned
|
Option
|
|||||||||||
or Paid in
|
Awards
|
|||||||||||
Name
|
Cash ($)
|
($)(1)
|
Total($)
|
|||||||||
Michael F. Angelo
|
38,500
|
85,240
|
123,740
|
|||||||||
Thomas M. O’Brien
|
44,000
|
85,240
|
129,240
|
|||||||||
Scott C. Taylor
|
38,500
|
85,240
|
123,740
|
(1)
|
The amounts in this column reflect amounts recognized for
financial statement reporting purposes for stock options granted in the
fiscal year ended December 31, 2008 and in prior fiscal years, in
accordance with Statement of Financial Standards (“ SFAS ”) No. 123R, “Share-Based Payment” (“ SFAS
123R ”). However, these amounts do not
include any reduction for risk of forfeiture related to service-based
vesting. The option awards included in this expense amount were granted
from December 31, 2007 through December 31, 2008. These amounts
reflect our accounting expense for these awards and do not represent the
actual value that may be realized by our non-executive directors. There
can be no assurance that these amounts will ever be realized. The
outstanding options held by each director at 2008 year end were as
follows: Mr. Angelo (40,000), Mr. O’Brien (40,000) and
Mr. Taylor (40,000.)
|
Securities
Beneficially Owned Prior to Offering
|
Beneficial Ownership
After the Offering
|
||||||||
Name
of selling security holder
|
Shares
of Common Stock being registered
|
Shares
of Common Stock Underlying Warrants being registered+
|
Other
Shares and Shares Underlying other Warrants
|
Total
Shares Beneficially Owned+
|
Number
of Total Shares Being Registered
|
Total
Shares Owned After Offering (1)
|
Percent
(2)
|
||
Albert
James Poliak (26)
|
-
|
37,906
|
-
|
30,575
|
37,906
|
-
|
*
|
||
Anthony
Athanas
|
39,682
|
129,195
|
22,500(3)
|
181,862
|
168,877
|
22,500
|
*
|
||
Bret
Marc Shapiro (27)
|
-
|
15,965
|
-
|
12,877
|
15,965
|
-
|
*
|
||
Capital
Ventures International (4)
|
496,032
|
1,614,956
|
-
|
1,992,064
|
2,110,988
|
-
|
*
|
||
Chad
K. Kirby
|
55,555
|
180,874
|
43,945(5)
|
267,053
|
236,429
|
43,945
|
*
|
||
Charles
Curtis
|
39,682
|
129,195
|
5,500(6)
|
164,862
|
168,877
|
5,500
|
*
|
||
Dawson
James Securities, Inc. (7)
|
-
|
57,997
|
-
|
46,781
|
57,997
|
-
|
*
|
||
Douglas
F. Kaiser (28)
|
-
|
37,906
|
-
|
30,575
|
37,906
|
-
|
*
|
||
Drs.
Robert F. & Qin C. Ryan
|
19,841
|
64,598
|
18,750(8)
|
98,431
|
84,439
|
18,750
|
*
|
||
Frank
Salvatore (29)
|
-
|
37,906
|
-
|
30,575
|
37,906
|
-
|
*
|
||
Gregory
A. Harrison
|
39,682
|
129,195
|
36,000(9)
|
195,362
|
168,877
|
36,000
|
*
|
||
Gregory
J. Wood (10)
|
63,492
|
206,715
|
1,008,000(11)
|
1,262,983
|
270,207
|
1,008,000
|
*
|
||
Gus
Blass II
|
59,523
|
193,793
|
359,900(12)
|
598,944
|
253,316
|
359,900
|
*
|
||
Hudson
Bay Fund LP (13)
|
178,572
|
581,387
|
-
|
717,145
|
759,959
|
-
|
*
|
||
Hudson
Bay Overseas Fund Ltd. (14)
|
317,459
|
1,033,568
|
-
|
1,274,915
|
1,351,027
|
-
|
*
|
||
Jay
R. Angle
|
95,238
|
310,072
|
10,000
(24)
|
392,475
|
405,310
|
10,000
|
*
|
||
Jay
R. Kuhne
|
79,365
|
258,393
|
-
|
318,729
|
337,758
|
-
|
*
|
||
John
Baleno
|
11,904
|
38,757
|
-
|
47,806
|
50,661
|
-
|
*
|
||
John
J. Blum Jr.
|
59,523
|
193,793
|
30,000
(25)
|
269,044
|
253,316
|
30,000
|
*
|
||
John
R. Rogers
|
43,650
|
142,114
|
7,500(15)
|
182,798
|
185,764
|
7,500
|
*
|
||
Joseph
Thomas Watters, III
|
39,682
|
129,195
|
11,900(16)
|
171,262
|
168,877
|
11,900
|
*
|
||
Kenneth
J. Licht
|
39,682
|
129,195
|
100,000(17)
|
259,362
|
168,877
|
100,000
|
*
|
||
Nancy
L. Schmid
|
59,523
|
193,793
|
516,574(18)
|
755,618
|
253,316
|
516,574
|
*
|
||
Peter
Wardenburg, Trustee, Wardenburg 2009 Family Trust (19)
|
39,682
|
129,195
|
-
|
159,362
|
168,877
|
-
|
*
|
||
Ramius
Advisors, LLC (20)
|
595,237
|
1,937,943
|
-
|
2,390,471
|
2,533,180
|
-
|
*
|
||
Ramius
Enterprise Master Fund Ltd. (21)
|
178,571
|
581,383
|
-
|
717,141
|
759,954
|
-
|
*
|
||
RCG
PB, Ltd. (22)
|
416,666
|
1,356,560
|
-
|
1,673,330
|
1,773,226
|
-
|
*
|
||
Robert
D. Keyser, Jr. (30)
|
-
|
37,906
|
-
|
30,575
|
37,906
|
-
|
*
|
||
Scott
E. Schalk (31)
|
-
|
40,171
|
-
|
32,402
|
40,171
|
-
|
*
|
||
Thomas
Russell Curtis
|
-
|
25,705
|
46,400(32)
|
67,134
|
25,705
|
46,400
|
*
|
||
Thomas
W. Hands (33)
|
-
|
3,720
|
-
|
3,000
|
3,720
|
-
|
*
|
||
Vestal
Venture Capital (23)
|
7,936
|
25,838
|
-
|
31,870
|
33,774
|
-
|
*
|
(1)
|
The
identified selling security holders provided us with information with
respect to their securities ownership. Because the selling
security holders may sell all, part or none of their respective shares or
other securities, we are unable to estimate the number of shares or other
securities that will be held by the selling security holders upon resale
of the securities being offered by this prospectus. We have,
therefore, assumed for the purposes of the registration statement related
to this prospectus that the selling security holders will sell all of
their securities. See “Plan of
Distribution.”
|
(2)
|
Calculated
based on Rule 13(d)-3(d)(1)(i) of the Exchange Act using 39,750,927 shares
of common stock outstanding as of September 11, 2009. In
calculating each respective selling security holder’s percentage, we did
not assume the issuance of any other shares issuable upon exercise of
outstanding warrants except for those underlying the holder’s own
derivative securities.
|
(3)
|
Warrants
to purchase 22,500 shares of common stock previously acquired by Mr.
Athanas.
|
(4)
|
Heights
Capital Management, Inc., the authorized agent of Capital Ventures
International (“CVI”), has discretionary authority to vote and dispose of
the shares held by CVI and may be deemed to be the beneficial owner of
these shares. Martin Kobinger,
in his capacity as Investment Manager of Heights Capital Management, Inc.,
may also be deemed to have investment discretion and voting power over the
shares held by CVI. Mr. Kobinger disclaims any such beneficial ownership
of the shares. CVI is not a registered broker-dealer. CVI is affiliated
with one or more registered broker-dealers. CVI purchased the shares being
registered hereunder in the ordinary course of business and at the time of
purchase, had no agreements or understandings, directly or indirectly,
with any other person to distribute such
shares.
|
(5)
|
Shares
of common stock previously acquired by Mr.
Kirby.
|
(6)
|
Includes
warrants to purchase 5,500 shares of common stock previously acquired by
Mr. Curtis.
|
(7)
|
Dawson
James is a registered broker-dealer that received a warrant to purchase
238,094 shares of common stock in connection with serving as placement
agent for the private placement transaction. The warrant is
initially exercisable for $3.93 per share. Mr. Albert J. Poliak, President
of Dawson James, has voting and investment power over these
securities. 191,313 of the initial 238,094 warrants have been
transferred to registered brokers affiliated with Dawson James who are
listed in this table as Selling Security
Holders.
|
(8)
|
Warrants
to purchase 18,750 shares of common stock previously acquired by Drs.
Robert F. & Qin C. Ryan.
|
(9)
|
Warrants
to purchase 36,000 shares of common stock previously acquired by Mr.
Harrison.
|
(10)
|
Mr.
Wood is the Senior Director of Corporate Communications of VirnetX Holding
Corporation.
|
(11)
|
Includes
908,000 shares of common stock previously acquired by Mr. Wood, 50,000
shares of common stock held in the name of The Dustan D. Sheehan
Irrevocable Trust, and 50,000 shares of common stock held in the name of
The Joshua D. Sheehan Irrevocable Trust (collectively, the
“Trusts”). Mr. Wood serves as trustee of the Trusts and
exercises voting and investment power over the shares of common stock held
by the Trusts.
|
(12)
|
Includes
269,900 shares of common stock and warrants to purchase 90,000 shares of
common stock previously acquired by Mr.
Blass.
|
(13)
|
Sander
Gerber has voting and investment power over these
securities. Sander Gerber disclaims beneficial ownership over
the securities held by Hudson Bay Fund LP. The selling
stockholder acquired the securities offered for its own account in the
ordinary course of business, and at the time it acquired the securities,
it had no agreements, plans or understandings, directly or indirectly to
distribute the securities.
|
(14)
|
Sander
Gerber has voting and investment power over these
securities. Sander Gerber disclaims beneficial ownership over
the securities held by Hudson Bay Overseas Fund Ltd. The
selling stockholder acquired the securities offered for its own account in
the ordinary course of business, and at the time it acquired the
securities, it had no agreements, plans or understandings, directly or
indirectly to distribute the
securities.
|
(15)
|
Warrants
to purchase 7,500 shares of common stock previously acquired by Mr.
Rogers.
|
(16)
|
Shares
of common stock previously acquired by Mr.
Watters.
|
(17)
|
Shares
of common stock previously acquired by Mr.
Licht.
|
(18)
|
Includes
466,574 shares of common stock previously acquired by Ms. Schmid and
50,000 shares of common stock held in the name of The Parker W. Larsen
Irrevocable Trust (the “Trust”). Ms. Schmid serves as trustee of the Trust
and exercises voting and investment power over the shares of common stock
held by the Trust.
|
(19)
|
Peter
Wardenburg, as Trustee of the Wardenburg 2009 Family Trust, has voting and
investment control over the shares of common stock and warrants held by
the Wardenburg 2009 Family Trust.
|
(20)
|
Ramius
Advisors, LLC (“Ramius Advisors”) is the investment manager of Ramius
Enterprise Master Fund Ltd (“Ramius Enterprise”) and RCG PB, Ltd. (“RCG
PB”) and consequently has voting control and investment discretion over
securities held by Ramius Enterprise and RCG PB.
Ramius
Advisors did not participate directly as an investor in the Company’s
private placement transaction on September 11, 2009
and did not purchase any shares of the Company’s common stock or warrants
to purchase shares of the Company’s common
stock. The 2,533,180 shares of the Company’s
common stock registered for Ramius Advisors’ account in the selling
security holder table reflect the sum of the shares of common stock and
shares of common stock underlying the Series I Warrants, Series II
Warrants and Series III Warrants held directly by Ramius Enterprise and
RCG PB, in the amounts of 759,954 and 1,773,226,
respectively.
|
|
Ramius
Advisors disclaims beneficial ownership of these
securities. Ramius LLC (“Ramius”) is the managing member of
Ramius Advisors and may be considered the beneficial owner of any
securities deemed to be beneficially owned by Ramius
Advisors. Ramius disclaims beneficial ownership of these
securities. Cowen Group, Inc. (“Cowen”) is the managing member
of Ramius and may be considered the beneficial owner of any securities
deemed to be beneficially owned by Ramius. Cowen disclaims
beneficial ownership of these securities. RCG Holdings LLC
(“RCG Holdings”) is the majority shareholder of Cowen and may be
considered the beneficial owner of any securities deemed to be
beneficially owned by Cowen. RCG Holdings disclaims beneficial
ownership of these securities. C4S & Co., L.L.C. (“C4S”) is
the managing member of RCG Holdings and may be considered the beneficial
owner of any securities deemed to be beneficially owned by RCG
Holdings. C4S disclaims beneficial ownership of these
securities. Peter A. Cohen, Morgan B. Stark, Thomas W. Strauss
and Jeffrey M. Solomon are the sole managing members of C4S and may be
considered beneficial owners of any securities deemed to be beneficially
owned by C4S. Messrs. Cohen, Stark, Strauss and Solomon
disclaim beneficial ownership of these
securities.
|
|
Ramius
Advisors is not a registered broker-dealer. The
investment adviser to RCG PB, Ltd and Ramius Enterprise Master Fund Ltd is
Ramius Advisors, LLC. An affiliate of Ramius Advisors , LLC is a FINRA member and a
registered broker-dealer. However,
this affiliate will not sell any shares to be
offered by RCG PB or Ramius Enterprise
through the prospectus and will receive no
compensation whatsoever in connection with the
sales of shares by RCG PB or Ramius Enterprise
through the
prospectus.
|
(21)
|
Ramius
Advisors is the investment manager of Ramius Enterprise and consequently
has voting control and investment discretion over securities held by
Ramius Enterprise. Ramius Advisors disclaims beneficial
ownership of these securities. Ramius is the managing member of
Ramius Advisors and may be considered the beneficial owner of any
securities deemed to be beneficially owned by Ramius
Advisors. Ramius disclaims beneficial ownership of these
securities. Cowen Group, Inc. (“Cowen”) is the managing member
of Ramius and may be considered the beneficial owner of any securities
deemed to be beneficially owned by Ramius. Cowen disclaims
beneficial ownership of these securities. RCG Holdings LLC
(“RCG Holdings”) is the majority shareholder of Cowen and may be
considered the beneficial owner of any securities deemed to be
beneficially owned by Cowen. RCG Holdings disclaims beneficial
ownership of these securities. C4S is the managing
member of RCG Holdings and may be considered the beneficial owner of any
securities deemed to be beneficially owned by RCG Holdings. C4S
disclaims beneficial ownership of these securities. Peter A.
Cohen, Morgan B. Stark, Thomas W. Strauss and Jeffrey M. Solomon are the
sole managing members of C4S and may be considered beneficial owners of
any securities deemed to be beneficially owned by C4S. Messrs.
Cohen, Stark, Strauss and Solomon disclaim beneficial ownership of these
securities.
Ramius
Enterprise is not a registered broker-dealer. Ramius Enterprise
is an affiliate of a registered broker-dealer. The investment
adviser to Ramius Enterprise is Ramius Advisors. An affiliate
of Ramius Advisors is a registered broker-dealer. However, this
affiliate will not sell any shares to be offered by Ramius Enterprise
through this prospectus and will receive no compensation whatsoever in
connection with sales of shares by Ramius Enterprise through this
prospectus. Ramius Enterprise purchased the shares
being registered hereunder in the ordinary course of business and at the
time of purchase, had no agreements or understandings, directly or
indirectly, with any other person to distribute such
shares.
|
(22)
|
Ramius
Advisors is the investment manager of RCG PB, Ltd and consequently has
voting control and investment discretion over securities held by RCG
PB. Ramius Advisors disclaims beneficial ownership of these
securities. Ramius is the managing member of Ramius Advisors
and may be considered the beneficial owner of any securities deemed to be
beneficially owned by Ramius Advisors. Ramius disclaims
beneficial ownership of these securities. Cowen Group, Inc.
(“Cowen”) is the managing member of Ramius and may be considered the
beneficial owner of any securities deemed to be beneficially owned by
Ramius. Cowen disclaims beneficial ownership of these
securities. RCG Holdings LLC (“RCG Holdings”) is the majority
shareholder of Cowen and may be considered the beneficial owner of any
securities deemed to be beneficially owned by Cowen. RCG
Holdings disclaims beneficial ownership of these
securities. C4S is the managing member of RCG Holdings and may
be considered the beneficial owner of any securities deemed to be
beneficially owned by RCG Holdings. C4S disclaims beneficial
ownership of these securities. Peter A. Cohen, Morgan B. Stark,
Thomas W. Strauss and Jeffrey M. Solomon are the sole managing members of
C4S and may be considered beneficial owners of any securities deemed to be
beneficially owned by C4S. Messrs. Cohen, Stark, Strauss and
Solomon disclaim beneficial ownership of these
securities.
|
(23)
|
Allan
R. Lyons, as managing member of the managing general partner of Vestal
Venture Capital, has voting and investing control over the shares held by
Vestal Venture Capital. Vestal Venture Capital is not a
registered broker-dealer. Vestal Venture Capital is an
affiliate of a registered broker-dealer. Vestal
Venture Capital purchased the shares being registered hereunder in the
ordinary course of business and at the time of purchase, had no agreements
or understandings, directly or indirectly, with any other person to
distribute such
shares.
|
(24)
|
Shares
of common stock previously acquired by Mr. Angle.
|
(25)
|
Includes
warrants to purchase 15,000 shares of common stock and 15,000 shares of
common stock previously acquired by Mr. Blum.
|
(26)
|
Mr.
Poliak is a registered broker-dealer and is affiliated with Dawson James
Securities, Inc.
|
(27)
|
Mr.
Shapiro is a registered broker-dealer and is affiliated with Dawson James
Securities, Inc.
|
(28)
|
Mr.
Kaiser is a registered broker-dealer and is affiliated with Dawson James
Securities, Inc.
|
(29)
|
Mr.
Salvatore is a registered broker-dealer and is affiliated with Dawson
James Securities, Inc.
|
(30)
|
Mr.
Keyser is a registered broker-dealer and is affiliated with Dawson James
Securities, Inc.
|
(31)
|
Mr.
Schalk is a registered broker-dealer and is affiliated with Dawson James
Securities, Inc.
|
(32)
|
Shares
of common stock previously acquired by Mr. Curtis. Mr. Curtis
is a registered broker-dealer and is affiliated with Dawson James
Securities, Inc.
|
(33)
|
Mr.
Hands is a registered broker-dealer and is affiliated with Dawson James
Securities, Inc.
|
|
|
·
|
ordinary
brokerage transactions and transactions in which the broker-dealer
solicits purchasers;
|
|
·
|
block
trades in which the broker-dealer will attempt to sell the shares as agent
but may position and resell a portion of the block as principal to
facilitate the transaction;
|
|
·
|
purchases
by a broker-dealer as principal and resale by the broker-dealer for its
account;
|
|
·
|
an
exchange distribution in accordance with the rules of the applicable
exchange;
|
|
·
|
privately
negotiated transactions;
|
|
·
|
settlement
of short sales entered into after the effective date of the registration
statement of which this prospectus is a
part;
|
|
·
|
in
transactions through broker-dealers that agree with the selling security
holders to sell a specified number of such shares at a stipulated price
per share;
|
|
·
|
through
the writing or settlement of options or other hedging transactions,
whether through an options exchange or
otherwise;
|
|
·
|
a
combination of any such methods of sale;
or
|
|
·
|
any
other method permitted pursuant to applicable
law.
|
|
●
|
The
Series I Warrants give the investors in the transaction rights to
purchase the same number of shares purchased in the transaction over
a 5-year term at an exercise price equal to 125% of the price per share
paid in the transaction, subject to anti-dilution protection that
could reduce the exercise price; provided however, that in no event shall
such exercise price be reduced to less than $3.17 (the closing price per
share of our common stock) subject to adjustments for reverse and forward
stock splits, stock dividends, stock combinations and other similar
transactions affecting the Company’s common stock. The Series I Warrants
are not exercisable until March 11, 2010 and expire on March 11,
2015. Aside from the anti-dilution adjustment associated with
the exercise price premium, the Series I Warrants are not subject to any
further adjustments with respect to the exercise price or number of shares
covered. The aggregate number of shares of common stock
registered by this prospectus includes 627, 923
shares of our common stock issuable pursuant to the
anti-dilution protection provisions described above. We
will not receive proceeds from any shares issued pursuant to the
anti-dilution protection
provisions.
|
|
●
|
The
Series II Warrants give the investors in the transaction pricing
protection for the transaction with a floor price of $1.25 per
share. In the event the market price of our common stock
declines between the closing of the transaction and the earlier of (i) 15
business days after the date this registration statement is declared
effective and (ii) the date Rule 144 becomes available for resale of the
common stock registered pursuant to this prospectus (such date that is the
earlier of clause (i) and (ii) is referred to in this registration
statement as the “Warrant Exercise Date”), the Series II Warrants will be
automatically exercised on a cashless exercise basis and a number of
additional shares will be issued to the investors in order to effectively
reduce the per share purchase price paid in the private placement
transaction to the greater of (i) 80% of the 15-day volume weighted
average trading price per share of our common stock immediately prior to
the Warrant Exercise Date and (ii) $1.25 per share. At the
Warrant Exercise Date, the Series II Warrants will either be automatically
exercised on a cashless exercise basis if our stock price is lower at the
Warrant Exercise Date as described above, or they will terminate
unexercised. The adjustment associated with the Series II
Warrants does not affect either the exercise price or number of shares
covered by either the Series I Warrants or the Series III
Warrants.
|
|
●
|
At
the Warrant Exercise Date, the Series III Warrants give the investors in
the transaction a 60-day right to purchase an additional $6.0 million
of our common stock at $2.52 per share. The Series III Warrants
are not subject to any adjustments with respect to the exercise price or
number of shares covered.
|
Series I
Warrants
|
Series II
Warrants
|
Series III
Warrants
|
|
Number
of shares issuable upon exercise of warrants
|
3,246,959
|
2,419,045
|
2,380,942
|
Time
frame during which the warrants can be exercised (1)
|
The
Series I Warrants are exercisable commencing on March 11, 2010 and ending
on March 11, 2015.
|
At
the Warrant Exercise Date (as defined above), the Series II Warrants will
either be automatically exercised on a cashless exercise basis if our
stock price is lower at the Warrant Exercise Date as described above, or
they will terminate unexercised.
|
At
the Warrant Exercise Date, the Series III Warrants give the investors in
the transaction a 60-day right to purchase an additional $6.0 million of
our common stock at $2.52 per share.
|
Percentage
of shares currently outstanding represented by the shares underlying each
series of warrant (1)
|
8.2%
|
6.1%
|
6.0%
|
Economic
effect of exercise of warrants on existing stockholders (2)
|
n/a
(3)
|
$1.93
(4)
|
n/a
(3)
|
|
·
|
A staggered Board of
Directors: this means that only one or two directors
(since we have a five person Board of Directors) will be up for election
at any given annual meeting. This has the effect of delaying the ability
of stockholders to effect a change in control of the Board of Directors
since it will take two annual meetings to effectively replace at least
three directors which represents a majority of the Board of
Directors.
|
|
·
|
Blank check preferred
stock: our Board of Directors has the authority to
establish the rights, preferences and privileges of our 10,000,000
authorized but unissued shares of preferred stock. Therefore, this stock
may be issued at the discretion of our Board of Directors with preferences
over your shares of common stock in a manner that is materially dilutive
to exiting stockholders. In addition, blank check preferred stock can be
used to create a “poison pill” which is designed to deter a hostile bidder
from buying a controlling interest in our stock without the approval of
our Board of Directors. We have not adopted such a “poison pill,” but our
Board of Directors will have the ability to do so in the future very
rapidly and without stockholder
approval.
|
|
·
|
Advance notice requirements
for director nominations and for new business to be brought up at
stockholder meetings: stockholders wishing to submit
director nominations or raise matters to a vote of the stockholders must
provide notice to us within very specific date windows in order to have
the matter voted on at the meeting. This has the effect of giving our
Board of Directors and management more time to react to stockholder
proposals generally and could also have the effect of delaying a
stockholder proposal to a subsequent meeting to the extent such proposal
is not raised in a timely manner for an upcoming
meeting.
|
|
·
|
Elimination of stockholder
actions by written consent: this has the effect of
eliminating the ability of a stockholder or a group of stockholders
representing a majority of the outstanding shares to take actions rapidly
and without prior notice to our Board of Directors and management or to
the minority stockholders. Along with the advance notice requirements
described above, this provision also gives our Board of Directors and
management more time to react to proposed stockholder
actions.
|
|
·
|
Super majority requirement for
stockholder amendments to the By-laws: our By-laws may
be altered or amended or new By-laws adopted by the affirmative vote of at
least 66-2/3% of the outstanding shares. This has the effect of requiring
a substantially greater vote of the stockholders to approve any changes to
our By-laws.
|
|
·
|
Elimination of the ability of
stockholders to call a special meeting of the
stockholders: only the Board of Directors or management
can call special meetings of the stockholders. This could mean that
stockholders, even those who represent a significant block of shares, may
need to wait for the annual meeting before nominating directors or raising
other business proposals to be voted on by the
stockholders.
|
Quarter
Ended
|
High
|
Low
|
||||||
3/31/07
|
$ | 5.97 | $ | 0.63 | ||||
6/30/07
|
$ | 5.10 | $ | 3.33 | ||||
9/30/07
|
$ | 5.10 | $ | 3.96 | ||||
12/31/07
|
$ | 6.75 | $ | 4.08 | ||||
3/31/08
|
$ | 6.95 | $ | 4.26 | ||||
6/30/08
|
$ | 7.06 | $ | 3.50 | ||||
9/30/08
|
$ | 4.07 | $ | 1.26 | ||||
12/31/08
|
$ | 2.98 | $ | 0.89 | ||||
3/31/09
|
$ | 1.55 | $ | 1.06 | ||||
6/30/09
|
$ | 2.00 | $ | 1.05 | ||||
9/30/09
|
$ | 5.00 | $ | 1.20 |
Plan
Category
|
Number of Securities to be Issued Upon Exercise
of Outstanding Options,
Warrants and Rights
(a)
|
Weighted-Average Exercise Price of Outstanding Options, Warrants and
Rights
(b)
|
Number of Securities Remaining Available for Future Issuance Under Equity
Compensation Plans Excluding Securities
Reflected in Column (a)
(c)
|
|||
Equity compensation plans approved by security
holders
|
4,468,595
|
2.98
|
2,651,392
|
|||
Equity compensation plans not approved by security
holders
|
—
|
—
|
||||
Total
|
4,468,595
|
2.98
|
2,651,392
|
Page
|
|
Report
of Farber Hass Hurley LLP, Independent Registered Public Accounting
Firm
|
F-2
|
Consolidated
Financial Statements
|
|
Consolidated
Balance Sheets of VirnetX Holding Corporation for the years ended December
31, 2008 and December 31, 2007
|
F-3
|
Consolidated
Statements of Operations of VirnetX Holding Corporation for the years
ended December 31, 2008 and December 31, 2007 and for the period from
August 2, 2005 (date of inception) to December 31, 2008
|
F-4
|
Consolidated
Statements of Stockholders’ Equity (Deficit) of VirnetX Holding
Corporation for the years ended December 31, 2008 and December 31, 2007
and for the period from August 2, 2005 (date of inception) to December 31,
2008
|
F-5
|
Consolidated
Statements of Cash Flows of VirnetX Holding Corporation for the years
ended December 31, 2008 and December 31, 2007 and for the period from
August 2, 2005 (date of inception) to December 31, 2008
|
F-6
|
Notes to
Financial Statements of VirnetX Holding Corporation
|
F-7
|
Unaudited Condensed
Consolidated Financial Statements
|
|
Condensed
Consolidated Balance Sheets at September 30, 2009 and
December 31, 2008
|
F-17
|
Condensed
Consolidated Statements of Operations for the three and nine months ended
September 30, 2009 and 2008
|
F-18
|
Condensed
Consolidated Statements of Cash Flows for the nine months ended
September 30, 2009 and 2008
|
F-19
|
Notes
to Condensed Consolidated Financial Statements
|
F-20
|
/s/ Farber Hass Hurley LLP |
As
of
December 31,
2008
|
As
of
December 31,
2007
|
|||||||
ASSETS
|
||||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$ | 457,155 | $ | 8,589,447 | ||||
Accounts
receivable
|
1,154 | 5,860 | ||||||
Prepaid
expenses and other current assets
|
189,847 | 399,201 | ||||||
Total
current assets
|
648,156 | 8,994,508 | ||||||
Property
and equipment, net
|
32,565 | 32,658 | ||||||
Intangible
and other assets
|
204,000 | 252,000 | ||||||
Deferred
offering costs
|
94,261 | --- | ||||||
Total
assets
|
$ | 978,982 | $ | 9,279,166 | ||||
LIABILITIES
AND STOCKHOLDERS’ EQUITY (DEFICIT)
|
||||||||
Current
liabilities:
|
||||||||
Accounts
payable and accrued liabilities
|
$ | 1,669,333 | $ | 531,790 | ||||
Current
portion of long-term obligation
|
44,000 | 48,000 | ||||||
Total
current liabilities
|
1,713,333 | 579,790 | ||||||
Long-term
obligation, net of current portion
|
160,000 | 204,000 | ||||||
Commitments
and contingencies:
|
— | — | ||||||
Stockholders’
equity (deficit):
|
||||||||
Preferred
stock, par value $0.0001 per share
|
||||||||
Authorized: 10,000,000 shares
at December 31, 2008 and December 31, 2007,
respectively
|
||||||||
Issued
and outstanding: 0 shares at December 31, 2008 and
December 31, 2007, respectively
|
||||||||
Common
stock, par value $0.0001 per share
|
||||||||
Authorized: 100,000,000 shares
at December 31, 2008 and December 31, 2007,
respectively
|
||||||||
Issued
and outstanding: 34,899,985 shares and
34,667,214 shares, at December 31, 2008 and December 31,
2007, respectively
|
3,489 | 3,467 | ||||||
Additional
paid-in capital
|
22,150,321 | 19,467,890 | ||||||
Deficit
accumulated during the development stage
|
(23,048,161 | ) | (10,975,981 | ) | ||||
Total
stockholders’ equity (deficit)
|
(894,351 | ) | 8,495,376 | |||||
Total
liabilities and stockholders’ equity (deficit)
|
$ | 978,982 | $ | 9,279,166 |
Year
Ended
December 31,
2008
|
Year
Ended
December 31,
2007
|
Cumulative
from
August 2,
2005
(Date
of Inception)
to
December 31,
2008
|
||||||||||
Revenue —
Royalties
|
$ | 133,744 | $ | 74,866 | $ | 208,610 | ||||||
Operating
expenses:
|
||||||||||||
Research
and development
|
845,324 | 684,316 | 2,139,827 | |||||||||
General
and administrative
|
11,510,008 | 8,040,894 | 21,230,868 | |||||||||
Total
operating expenses
|
12,355,332 | 8,725,210 | 23,370,695 | |||||||||
Loss
from operations
|
(12,221,588 | ) | (8,650,344 | ) | (23,162,085 | ) | ||||||
Interest
and other income (expense), net
|
149,408 | (41,820 | ) | 113,924 | ||||||||
Net
loss
|
$ | (12,072,180 | ) | $ | (8,692,164 | ) | $ | (23,048,161 | ) | |||
Basic
and diluted loss per share
|
$ | (.35 | ) | $ | (.36 | ) | ||||||
Weighted
average shares outstanding
|
34,875,471 | 24,312,287 |
Deficit
|
||||||||||||||||||||||||||||||||
Accumulated
|
Total
|
|||||||||||||||||||||||||||||||
Additional
|
Due
from
|
During
|
Stockholders’
|
|||||||||||||||||||||||||||||
Series
A Preferred Stock
|
Common
Stock
|
Paid-in
|
Stock-
|
Development
|
Equity
|
|||||||||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
holder
|
Stage
|
(Deficit)
|
|||||||||||||||||||||||||
Balance
at inception (August 2, 2005)
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
||||||||||||||||||||||||
Common
stock issued to founders
|
—
|
—
|
13,285,107
|
1,329
|
(1,129
|
)
|
—
|
—
|
200
|
|||||||||||||||||||||||
Proceeds
from issuance of restricted stock units to employees at $0.0001 per share
in October 2005
|
—
|
—
|
3,321,277
|
332
|
(252
|
)
|
—
|
—
|
80
|
|||||||||||||||||||||||
Stock-based
compensation from restricted stock units
|
—
|
—
|
—
|
—
|
799,920
|
—
|
—
|
799,920
|
||||||||||||||||||||||||
Net
loss
|
—
|
—
|
—
|
—
|
—
|
—
|
(882,478
|
)
|
(882,478
|
)
|
||||||||||||||||||||||
Balance
at December 31, 2005
|
—
|
—
|
16,606,384
|
1,661
|
798,539
|
0
|
(882,478
|
)
|
(82,278
|
)
|
||||||||||||||||||||||
Proceeds
from issuance of preferred stock at $1.00 per share in February 2006, net
of issuance cost of $26,375
|
1,404,000
|
1,377,625
|
—
|
—
|
—
|
—
|
—
|
1,377,625
|
||||||||||||||||||||||||
Proceeds
from issuance of restricted stock units to employees at $0.01 per share in
March and October 2006
|
—
|
—
|
975,625
|
97
|
1,953
|
(150
|
)
|
—
|
1,900
|
|||||||||||||||||||||||
Stock-based
compensation: restricted stock units
|
—
|
—
|
—
|
—
|
130,210
|
—
|
—
|
130,210
|
||||||||||||||||||||||||
Stock-based
compensation: employee stock options
|
—
|
—
|
—
|
—
|
81,619
|
—
|
—
|
81,619
|
||||||||||||||||||||||||
Net
loss
|
—
|
—
|
—
|
—
|
—
|
—
|
(1,401,339
|
)
|
(1,401,339
|
)
|
||||||||||||||||||||||
Balance
at December 31, 2006
|
1,404,000
|
1,377,625
|
17,582,009
|
1,758
|
1,012,321
|
(150
|
)
|
(2,283,817
|
)
|
107,737
|
||||||||||||||||||||||
Proceeds
from exercise of options
|
—
|
—
|
124,548
|
12
|
29,988
|
—
|
—
|
30,000
|
||||||||||||||||||||||||
Shares
issued for merger
|
—
|
—
|
1,665,800
|
167
|
—
|
—
|
—
|
167
|
||||||||||||||||||||||||
Debt
converted to stock, net
|
—
|
—
|
2,016,016
|
202
|
1,499,648
|
150
|
—
|
1,500,000
|
||||||||||||||||||||||||
Stock
issued for cash at $.75 per share, net
|
—
|
—
|
4,000,000
|
400
|
2,953,249
|
—
|
—
|
2,953,649
|
||||||||||||||||||||||||
Stock
issued for cash at $4.00 per share, net
|
—
|
—
|
3,450,000
|
345
|
11,776,773
|
—
|
—
|
11,777,118
|
||||||||||||||||||||||||
Stock-based
compensation
|
—
|
—
|
—
|
—
|
818,869
|
—
|
—
|
818,869
|
||||||||||||||||||||||||
Preferred
stock converted to common stock
|
(1,404,000
|
)
|
(1,377,625
|
)
|
5,828,841
|
583
|
1,377,042
|
—
|
—
|
—
|
||||||||||||||||||||||
Net
loss
|
—
|
—
|
—
|
—
|
—
|
—
|
(8,692,164
|
)
|
(8,692,164
|
)
|
||||||||||||||||||||||
Balance
at December 31, 2007
|
—
|
—
|
34,667,214
|
3,467
|
19,467,890
|
—
|
(10,975,981
|
)
|
8,495,376
|
|||||||||||||||||||||||
Cashless
exercise of warrants
|
—
|
—
|
232,771
|
22
|
—
|
—
|
—
|
22
|
||||||||||||||||||||||||
Stock-based
compensation
|
—
|
—
|
—
|
—
|
2,682,431
|
—
|
—
|
2,682,431
|
||||||||||||||||||||||||
Net
loss
|
—
|
—
|
—
|
—
|
—
|
—
|
(12,072,180
|
)
|
(12,072,180
|
)
|
||||||||||||||||||||||
Balance
at December 31, 2008
|
—
|
—
|
34,899,985
|
$
|
3,489
|
$
|
22,150,321
|
—
|
$
|
(23,048,161
|
)
|
$
|
(894,351
|
)
|
||||||||||||||||||
Year
Ended
December 31,
2008
|
Year
Ended
December 31,
2007
|
Cumulative
Period
from
August 2,
2005
(Date
of Inception)
to
December 31,
2008
|
||||||||||
Cash
flows from operating activities:
|
||||||||||||
Net
loss
|
$ | (12,072,180 | ) | $ | (8,692,164 | ) | $ | (23,048,161 | ) | |||
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
||||||||||||
Stock-based
compensation
|
2,682,431 | 818,869 | 4,513,049 | |||||||||
Depreciation
and amortization
|
68,623 | 18,609 | 94,921 | |||||||||
Changes
in assets and liabilities:
|
||||||||||||
Prepaid
expenses and other assets
|
119,799 | (392,256 | ) | (300,496 | ) | |||||||
Accounts
payable and accrued liabilities
|
1,137,751 | 444,404 | 1,669,541 | |||||||||
Net
cash used in operating activities
|
(8,063,576 | ) | (7,802,538 | ) | (17,071,146 | ) | ||||||
Cash
flows from investing activities:
|
||||||||||||
Purchase
of property and equipment
|
(20,716 | ) | (22,955 | ) | (78,447 | ) | ||||||
Cash
acquired in acquisition
|
— | 14,009 | 14,009 | |||||||||
Net
cash used in investing activities
|
(20,716 | ) | (8,946 | ) | (64,438 | ) | ||||||
Cash
flows from financing activities:
|
||||||||||||
Issuance
of notes payable
|
— | 250,000 | 250,000 | |||||||||
Repayment
of notes payable
|
— | (250,000 | ) | (250,000 | ) | |||||||
Proceeds
from issuance of preferred stock, net of issuance costs
|
— | — | 1,147,625 | |||||||||
Proceeds
from issuance of restricted stock units
|
— | — | 2,180 | |||||||||
Proceeds
from advance from preferred stockholders
|
— | — | 230,000 | |||||||||
Proceeds
from exercise of options
|
— | 30,000 | 30,000 | |||||||||
Proceeds
from convertible debt
|
— | 1,500,000 | 1,500,000 | |||||||||
Payment
of royalty obligation less imputed interest
|
(48,000 | ) | — | (48,000 | ) | |||||||
Proceeds
from sale of common stock
|
— | 14,730,934 | 14,730,934 | |||||||||
Net
cash provided by (used in) financing activities
|
(48,000 | ) | 16,260,934 | 17,592,739 | ||||||||
Net
increase in cash and cash equivalents
|
(8,132,292 | ) | 8,449,450 | 457,155 | ||||||||
Cash
and cash equivalents, beginning of period
|
8,589,447 | 139,997 | — | |||||||||
Cash
and cash equivalents, end of period
|
$ | 457,155 | $ | 8,589,447 | $ | 457,155 | ||||||
Supplemental
disclosure of cash flow information:
|
||||||||||||
Cash
paid during the year for taxes
|
$ | 9,201 | $ | 800 | $ | 10,801 | ||||||
Cash
paid during the year for interest
|
$ | 5,622 | $ | 41,630 | $ | 47,252 | ||||||
Supplemental
disclosure of noncash investing and financing activities:
|
||||||||||||
Conversion
of advance into preferred stock
|
$ | — | $ | — | $ | 230,000 | ||||||
Royalty
obligation assumed to obtain intangible assets
|
$ | — | $ | 252,000 | $ | 252,000 |
December 31
|
||||||||
2008
|
2007
|
|||||||
Office
furniture
|
$ | 17,239 | $ | 10,129 | ||||
Computer
equipment
|
61,209 | 48,827 | ||||||
Total
|
78,448 | 58,956 | ||||||
Less
accumulated depreciation
|
(45,883 | ) | (26,298 | ) | ||||
$ | 32,565 | $ | 32,658 |
2009
|
$ | 48,000 | ||
2010
|
48,000 | |||
2011
|
48,000 | |||
2012
|
48,000 | |||
Thereafter
|
12,000 | |||
Total
|
$ | 204,000 |
2009
|
$ | 44,000 | ||
2010
|
40,000 | |||
2011
|
36,000 | |||
2012
|
32,000 | |||
Thereafter
|
52,000 | |||
Total
|
$ | 204,000 |
For the Year
|
Minimum
Required
Lease
Payments
in
Period
|
|||
2009
|
$ | 44,373 | ||
2010
|
54,595 | |||
2011
|
59,242 | |||
2012
|
30,202 | |||
$ | 188,412 |
Options
Outstanding
|
||||||||||||
Shares
Available
for
Grant
|
Number
of
Shares
|
Weighted
Average Exercise Price
|
||||||||||
Shares
reserved for the Plan at inception
|
11,624,469 | — | — | |||||||||
Restricted
stock units granted
|
(3,321,277 | ) | — | — | ||||||||
Options
granted
|
— | — | — | |||||||||
Options
exercised
|
— | — | — | |||||||||
Options
cancelled
|
— | — | — | |||||||||
Balance
at December 31, 2005
|
8,303,192 | — | — | |||||||||
Restricted
stock units granted
|
(1,058,657 | ) | — | — | ||||||||
Options
granted
|
(1,868,218 | ) | 1,868,218 | $ | .24 | |||||||
Options
exercised
|
— | — | — | |||||||||
Options
cancelled
|
— | — | — | |||||||||
Balance
at December 31, 2006
|
5,376,317 | 1,868,218 | $ | .24 | ||||||||
Restricted
stock units granted
|
— | — | — | |||||||||
Options
granted
|
(2,324,925 | ) | 2,324,925 | 4.96 | ||||||||
Options
exercised
|
(124,548 | ) | .24 | |||||||||
Options
cancelled
|
— | — | — | |||||||||
Balance
at December 31, 2007
|
3,051,392 | 4,068,595 | $ | 2.94 | ||||||||
Restricted
stock units granted
|
— | — | — | |||||||||
Options
granted
|
(420,000 | ) | 420,000 | 3.42 | ||||||||
Options
exercised
|
--- | --- | --- | |||||||||
Options
cancelled
|
20,000 | (20,000 | ) | 4.20 | ||||||||
Balance
at December 31, 2008
|
2,651,392 | 4,468,595 | $ | 2.98 |
Stock-Based
Compensation
by Type
of
Award
|
Year
Ended
December 31,
2008
|
Year
Ended December 31,
2007
|
Cumulative
Period
from
August 2,
2005
(Date
of Inception)
to
December 31,
2008
|
|||||||||
Restricted
stock units
|
$ | - | $ | - | $ | 930,130 | ||||||
Employee
stock options
|
2,682,431 | 818,869 | 3,582,919 | |||||||||
Total
stock-based compensation
|
$ | 2,682,431 | $ | 818,869 | $ | 4,513,049 |
Year
Ended
December 31,
2008
|
Year
Ended
December 31,
2007
|
|
Volatility
|
190%
|
100%
|
Risk-free
interest rate
|
4.21%
|
3.32%
|
Expected
life
|
6.7 years
|
6.5 years
|
Expected
dividends
|
0%
|
0%
|
Weighted
|
||||||||||||
Average
|
||||||||||||
Weighted
|
Remaining
|
Aggregate
|
||||||||||
Number
of
Shares
|
Average
Exercise
|
Contractual
Life
(Years)
|
Intrinsic
Value
|
|||||||||
Outstanding
at December 31, 2005
|
- | - | ||||||||||
Options
granted
|
1,868,218 | 0.24 | ||||||||||
Options
exercised
|
- | - | ||||||||||
Options
cancelled
|
- | - | ||||||||||
Outstanding
at December 31, 2006
|
1,868,218 | 0.24 | ||||||||||
Options
granted
|
2,324,925 | 4.96 | ||||||||||
Options
exercised
|
(124,548 | ) | 0.24 | |||||||||
Options
cancelled
|
- | - | ||||||||||
Outstanding
at December 31, 2007
|
4,068,595 | 2.94 | ||||||||||
Options
granted
|
420,000 | 3.42 | ||||||||||
Options
exercised
|
- | - | ||||||||||
Options
cancelled
|
(20,000 | ) | 4.20 | |||||||||
Outstanding
at December 31, 2008
|
4,468,595 | $ | 2.98 |
8.7
|
$ |
2,160,633
|
Options
Outstanding
|
Options
Vested and Exercisable
|
|||||||||||||||||||||||||
Range
of
Exercise
Price
|
Number
Outstanding
|
Weighted
Average
Remaining
Contractual
Life (Years)
|
Weighted
Average
Exercise
Price
|
Number
Exercisable
|
Weighted
Average
Remaining
Contractual
Life (Years)
|
Weighted
Average
Exercise
Price
|
||||||||||||||||||||
$0.24 | 1,743,670 | 7.4 | $ | 0.24 | 1,138,230 | 7.4 | $ | 0.24 | ||||||||||||||||||
4.20 | 1,327,899 | 8.6 | 4.20 | 513,543 | 8.6 | 4.20 | ||||||||||||||||||||
5.88-6.47 | 977,026 | 9.0 | 6.00 | 264,257 | 9.0 | 6.00 | ||||||||||||||||||||
1.74-6.20 | 420,000 | 9.6 | 3.42 | 47,500 | 9.6 | 5.06 | ||||||||||||||||||||
4,468,595 | 8.7 | $ | 2.98 | 1,963,530 | 8.7 | $ | 2.17 |
Period Ended
December 31,
|
||||||||
2008
|
2007
|
|||||||
Net
loss
|
$ | (12,072 | ) | $ | (8,692 | ) | ||
Weighted
average number of shares outstanding
|
34,875 | 24,312 | ||||||
Basic
earnings (loss) per share
|
$ | (0.35 | ) | $ | (0.36 | ) |
2008
|
2007
|
|||||||
Options
|
4,468,595 | 4,068,595 | ||||||
Warrants
|
300,000 | 566,667 |
Period
Ended December 31,
|
||||||||
2008
|
2007
|
|||||||
Provision
for income taxes at the federal & state statutory rate
|
$ | (4,100,000 | ) | $ | (3,200,000 | ) | ||
Stock-based
compensation
|
900,000 | 300,000 | ||||||
Research
and development credits
|
(100,000 | ) | (100,000 | ) | ||||
Valuation
allowance
|
3,300,000 | 3,000,000 | ||||||
Tax
provision
|
$ | 0 | $ | 0 |
Period
Ended December 31,
|
||||||||
2008
|
2007
|
|||||||
Tax
benefit of net operating loss carryforwards
|
$ | 7,000,000 | $ | 3,400,000 | ||||
Research
and development credits
|
400,000 | 300,000 | ||||||
Subtotal
|
7,400,000 | 3,700,000 | ||||||
Less
valuation allowance
|
(7,400,000 | ) | (3,700,000 | ) | ||||
$ | 0 | $ | 0 |
|
Our
officers and directors, except for the chief financial officer, were
replaced upon completion of the transaction so that the officers and
directors of VirnetX, Inc. became our officers and
directors.
|
|
VirnetX,
Inc.’s convertible notes payable for $1,000,000 and $500,000 were
converted into our common stock in July
2007.
|
|
An
escrow account containing proceeds of $3,000,000 was released from escrow
in exchange for our issuance of common stock in July
2007.
|
|
We
issued 29,551,398 shares of our common stock and options to purchase
1,785,186 shares of common stock to the pre-merger shareholders,
convertible note holders and option holders of VirnetX, Inc. in exchange
for 100% of the issued and outstanding capital stock and securities of
VirnetX, Inc. Additionally, we issued to MDB Capital Group LLC
and its affiliates, warrants to purchase an aggregate of
266,667 shares of our common stock of the Company pursuant to the
provisions of the MDB Service Agreement, which we assumed from VirnetX,
Inc. in connection with the merger.
|
First
|
Second
|
Third
|
Fourth
|
|||||||||||||
(amounts
in thousands except per share)
|
||||||||||||||||
2008
|
||||||||||||||||
Revenue
|
$ | 33 | $ | 51 | $ | 24 | $ | 26 | ||||||||
Loss
from operations
|
(3,102 | ) | (3,096 | ) | (2,947 | ) | (3,077 | ) | ||||||||
Net
loss
|
(3,032 | ) | (3,049 | ) | (2,923 | ) | (3,068 | ) | ||||||||
Net
loss per common share
|
$ | (0.09 | ) | $ | (0.09 | ) | $ | (0.08 | ) | $ | (0.08 | ) | ||||
2007
|
||||||||||||||||
Revenue
|
$ | 0 | $ | 0 | $ | 47 | $ | 28 | ||||||||
Loss
from operations
|
(766 | ) | (1,233 | ) | (2,589 | ) | (4,137 | ) | ||||||||
Net
loss
|
(781 | ) | (1,231 | ) | (2,566 | ) | (4,114 | ) | ||||||||
Net
loss per common share
|
$ | (0.04 | ) | $ | (0.07 | ) | $ | (0.08 | ) | $ | (0.15 | ) | ||||
September
30,
2009
|
December
31,
2008
|
|||||||
(Unaudited)
|
||||||||
ASSETS
|
||||||||
Current
assets
|
||||||||
Cash
and cash equivalents
|
$
|
4,016,248
|
$
|
457,155
|
||||
Accounts
receivable, net
|
—
|
1,154
|
||||||
Prepaid
expense and other current assets
|
90,008
|
189,847
|
||||||
Total
current assets
|
4,106,256
|
648,156
|
||||||
Property
and equipment, net
|
23,994
|
32,565
|
||||||
Intangibles
|
168,000
|
204,000
|
||||||
Deferred
offering costs
|
—
|
94,261
|
||||||
Total
assets
|
$
|
4,298,250
|
$
|
978,982
|
||||
LIABILITIES
AND STOCKHOLDERS’ EQUITY (DEFICIT)
|
||||||||
Current
liabilities
|
||||||||
Accounts
payable and accrued expenses
|
$
|
4,203,919
|
$
|
1,669,333
|
||||
Current
portion of long-term obligation
|
40,000
|
44,000
|
||||||
Total
current liabilities
|
4,243,919
|
1,713,333
|
||||||
Long-term
obligation, net of current portion
|
120,000
|
160,000
|
||||||
Commitments
and contingencies
|
||||||||
Stockholders’
equity (deficit)
|
||||||||
Preferred
stock, par value $0.0001 per share, authorized 10,000,000 shares; issued
and outstanding: 0 shares at September 30, 2009 and December 31, 2008,
respectively
|
—
|
—
|
||||||
Common
stock, par value $0.0001 per share, authorized 100,000,000 shares, issued
and outstanding: 39,750,927 shares at September 30, 2009 and 34,899,985 at
December 31, 2008, respectively
|
3,975
|
3,489
|
||||||
Additional
paid-in capital
|
32,931,376
|
22,150,321
|
||||||
Deficit
accumulated during the development stage
|
(33,001,020
|
)
|
(23,048,161
|
)
|
||||
Total
stockholders’ equity (deficit)
|
(65,669
|
)
|
(894,351
|
)
|
||||
Total
liabilities and stockholders’ equity (deficit)
|
$
|
4,298,250
|
$
|
978,982
|
Three
months ended
September
30, 2009
|
Three
months ended
September
30, 2008
|
|||||||
Revenue
— royalties
|
$
|
3,233
|
$
|
23,905
|
||||
Operating
expense
|
||||||||
Research
and development
|
215,243
|
215,513
|
||||||
General
and administrative
|
2,412,101
|
2,755,568
|
||||||
Total
operating expense
|
(2,627,344
|
)
|
(2,971,081
|
)
|
||||
Loss
from operations
|
(2,624,111
|
)
|
(2,947,176
|
)
|
||||
Interest
and other income, net
|
1,360
|
24,301
|
||||||
Net
loss
|
$
|
(2,622,751
|
)
|
$
|
(2,922,875
|
)
|
||
Basic
and diluted loss per share
|
$
|
(0.07
|
)
|
$
|
(0.08
|
)
|
||
Weighted
average shares outstanding
|
37,264,263
|
34,899,985
|
Nine
months ended
September
30, 2009
|
Nine
months ended September 30, 2008
|
For
the period
August
2, 2005
(Date
of Inception) to
September
30, 2009
|
||||||||||
Revenue
— royalties
|
$
|
13,594
|
$
|
107,955
|
$
|
222,204
|
||||||
Operating
expense
|
||||||||||||
Research
and development
|
657,499
|
633,335
|
2,797,326
|
|||||||||
General
and administrative
|
9,313,786
|
8,620,276
|
30,544,654
|
|||||||||
Total
operating expense
|
(9,971,285
|
)
|
(9,253,611
|
)
|
(33,341,980
|
)
|
||||||
Loss
from operations
|
(9,957,691
|
)
|
(9,145,656
|
)
|
(33,119,776
|
)
|
||||||
Interest
and other income, net
|
4,832
|
142,454
|
118,756
|
|||||||||
Net
loss
|
$
|
(9,952,859
|
)
|
$
|
(9,003,202
|
)
|
$
|
(33,001,020
|
)
|
|||
Basic
and diluted loss per share
|
$
|
(0.27
|
)
|
$
|
(0.26
|
)
|
||||||
Weighted
average shares outstanding
|
37,264,263
|
34,866,480
|
Nine
months ended
September
30, 2009
|
Nine
months ended
September
30, 2008
|
Cumulative
Period
from
August
2, 2005
(Date
of Inception) to September 30, 2009
|
||||||||||
Cash
flows from operating activities:
|
||||||||||||
Net
loss
|
$
|
(9,952,859
|
)
|
(9,003,202
|
)
|
(33,001,020
|
)
|
|||||
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
||||||||||||
Stock-based
compensation
|
2,232,876
|
1,915,544
|
6,745,925
|
|||||||||
Depreciation
and amortization
|
47,999
|
13,470
|
142,920
|
|||||||||
Changes
in assets and liabilities:
|
||||||||||||
Prepaid
expenses and other assets
|
100,993
|
(128,614)
|
(199,503
|
)
|
||||||||
Accounts
payable and accrued liabilities
|
2,534,586
|
937,644
|
4,204,127
|
|||||||||
Net
cash used in operating activities
|
(5,036,405
|
)
|
(6,265,158
|
)
|
(22,107,551
|
)
|
||||||
Cash
flows from investing activities:
|
||||||||||||
Purchase
of property and equipment
|
(3,430
|
)
|
(16,119
|
)
|
(81,877
|
)
|
||||||
Cash
acquired in acquisition
|
—
|
—
|
14,009
|
|||||||||
Net
cash used in investing activities
|
(3,430
|
)
|
(16,119
|
)
|
(67,868
|
)
|
||||||
Cash
flows from financing activities:
|
||||||||||||
Issuance
of notes payable
|
—
|
—
|
250,000
|
|||||||||
Repayment
of notes payable
|
—
|
—
|
(250,000
|
)
|
||||||||
Proceeds
from issuance of preferred stock, net of issuance
costs
|
—
|
—
|
1,147,625
|
|||||||||
Proceeds
from issuance of restricted stock units
|
—
|
—
|
2,180
|
|||||||||
Proceeds
from advance from preferred stockholders
|
—
|
—
|
230,000
|
|||||||||
Proceeds
from exercise of options
|
—
|
—
|
30,000
|
|||||||||
Proceeds
from convertible debt
|
—
|
—
|
1,500,000
|
|||||||||
Payment
of royalty obligation less imputed interest
|
(44,000
|
)
|
(48,000
|
)
|
(92,000
|
)
|
||||||
Proceeds
from sale of common stock and warrants, net
|
8,642,928
|
—
|
23,373,862
|
|||||||||
Net
cash provided by (used in) financing activities
|
8,598,928
|
(48,000
|
)
|
26,191,667
|
||||||||
Net
increase (decrease) in cash and cash equivalents
|
3,559,093
|
(6,329,277
|
)
|
4,016,248
|
||||||||
Cash
and cash equivalents, beginning of period
|
457,155
|
8,589,447
|
—
|
|||||||||
Cash
and cash equivalents, end of period
|
$
|
4,016,248
|
$
|
2,260,170
|
$
|
4,016,248
|
||||||
Supplemental
disclosure of cash flow information:
|
||||||||||||
Cash
paid during the period for taxes
|
$
|
5,373
|
$
|
—
|
$
|
15,374
|
||||||
Cash
paid during the period for interest
|
$
|
6,000
|
$
|
—
|
53,252
|
|||||||
Supplemental
disclosure of noncash investing and financing
activities:
|
||||||||||||
Conversion
of advance into preferred stock
|
$
|
—
|
$
|
—
|
$
|
230,000
|
||||||
Royalty
obligation assumed to obtain intangible assets
|
$
|
—
|
$
|
—
|
$
|
252,000
|
For
the Period
|
Minimum
Required
Lease
Payments
in
Period
|
|||
October
1 through December 31, 2009
|
$
|
12,778
|
||
2010
|
54,595
|
|||
2011
|
59,242
|
|||
2012
|
30,202
|
|||
$
|
156,817
|
Options
Outstanding
|
||||||||||||
Shares
Available
|
Number
|
Weighted
Average
|
||||||||||
for
Grant
|
of
Shares
|
Exercise
Price
|
||||||||||
Balance
at December 31, 2008
|
2,651,392
|
4,468,595
|
$
|
2.98
|
||||||||
Restricted
stock units granted
|
—
|
—
|
—
|
|||||||||
Options
granted
|
(1,317,195
|
)
|
1,317,195
|
1.18
|
||||||||
Options
exercised
|
—
|
—
|
—
|
|||||||||
Options
cancelled
|
—
|
—
|
—
|
|||||||||
Balance
at September 30, 2009
|
1,334,197
|
5,785,790
|
$
|
2.58
|
Nine
months
ended
September
30,
2009
|
Year
Ended
December
31,
2008
|
|||||||
Volatility
|
120.00
|
%
|
190.00
|
%
|
||||
Risk-free
interest rate
|
2.93
|
%
|
4.21
|
%
|
||||
Expected
life
|
6.1
years
|
6.7
years
|
||||||
Expected
dividends
|
0.00
|
%
|
0.00
|
%
|
||||
Weighted-average
grant date fair value of stock options granted
|
$
|
1.18
|
$
|
3.09
|
Amount to be
Paid
|
||||
SEC
registration fee
|
$
|
1,550.70
**
|
||
Legal
fees and expenses
|
$
|
20,000
|
||
Accounting
fees and expenses
|
$
|
12,000
|
||
Miscellaneous
|
$
|
10,000
|
||
Total
|
$
|
43,550.70
|
(i)
|
To
include any prospectus required by Section 10(a)(3) of the Securities Act
of 1933;
|
(ii)
|
To
reflect in the prospectus any facts or events arising after the effective
date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a
fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from
the low or high end of the estimated maximum offering range may be
reflected in the form of prospectus filed with the Commission pursuant to
Rule 424(b) if, in the aggregate, the changes in volume and price
represent no more than 20 percent change in the maximum aggregate offering
price set forth in the “Calculation of Registration Fee” table in the
effective registration
statement;
|
(iii)
|
To
include any material information with respect to the plan of distribution
not previously disclosed in the registration statement or any material
change to such information in the registration
statement;
|
VIRNETX HOLDING
CORPORATION
|
|||
By:
|
/s/
Kendall Larsen
|
||
Name: Kendall
Larsen
|
|||
Title: President
and Chief Executive Officer
|
|||
Signature and
Name
|
Capacity
|
Date
|
|
/s/ Kendall
Larsen
Kendall
Larsen
|
President,
Chief Executive Officer
(Principal
Executive Officer), Director, and Attorney-in-Fact
|
December
9, 2009
|
|
/s/ William E.
Sliney*
William
E. Sliney
|
Chief
Financial Officer (Principal
Accounting
and Financial Officer)
|
December
9, 2009
|
|
/s/ Edmund C.
Munger*
Edmund
C. Munger
|
Director
|
December
9, 2009
|
|
/s/ Scott C.
Taylor*
Scott
C. Taylor
|
Director
|
December
9, 2009
|
|
/s/ Michael F.
Angelo*
Michael
F. Angelo
|
Director
|
December
9, 2009
|
|
/s/ Thomas M.
O’Brien*
Thomas
M. O’Brien
|
Director
|
December
9, 2009
|
|
2.1
|
Agreement
and Plan of Merger of PASW, Inc., a Delaware corporation, and PASW, Inc.,
a California corporation dated May 25,
2007.(1)
|
2.2
|
Certificate
of Merger filed with the Secretary of State of the State of Delaware on
May 30, 2007.(1)
|
2.3
|
Agreement
and Plan of Merger and Reorganization among PASW, Inc., VirnetX
Acquisition, Inc. and VirnetX, Inc. dated as of June 12,
2007.(1)
|
3.1
|
Amended
and Restated Certificate of Incorporation of the Company.
(1)
|
3.2
|
Amended
and Restated Bylaws of the Company. (2)
|
4.1
|
Form
of Series I Warrant attached as Exhibit C-I to the Securities Purchase
Agreement dated September 2, 2009. (3)
|
4.2
|
Form
of Series II Warrant attached as Exhibit C-II to the Securities Purchase
Agreement dated September 2, 2009. (3)
|
4.3
|
Form
of Series III Warrant attached as Exhibit C-III to the Securities Purchase
Agreement dated September 2, 2009. (3)
|
4.4
|
Registration
Rights Agreement dated as of September 2, 2009 by and between VirnetX
Holding Corporation and each of the several purchasers signatory thereto.
(3)
|
4.5
|
Securities
Purchase Agreement, dated September 2, 2009, by and between VirnetX
Holding Corporation and each purchaser identified on the signature pages
thereto. (3)
|
5.1
|
Opinion
of Orrick, Herrington & Sutcliffe LLP.
|
10.1
|
Form
of Indemnification Agreement, dated as of July 5, 2007, by and
between the Company and each of Kendall Larsen, Edmund C. Munger, Scott C.
Taylor, Michael F. Angelo, Thomas M. O’Brien and William E.
Sliney.(1)
|
10.2
|
Patent
License and Assignment Agreement by and between the Company and Science
Applications International Corporation, dated as of August 12,
2005.(1)
|
10.3
|
Security
Agreement by and between the Company and Science Applications
International Corporation, dated as of August 12,
2005.(1)
|
10.4
|
Amendment
No. 1 to Patent License and Assignment Agreement by and between the
Company and Science Applications International Corporation, dated as of
November 2, 2006.(1)
|
10.5
|
Assignment
Agreement between the Company and Science Applications International
Corporation, dated as of December 21,
2006.(1)
|
10.6
|
Professional
Services Agreement by and between the Company and Science Applications
International Corporation, dated as of August 12,
2005.(1)
|
10.7
|
Voting
Agreement among the Company and certain of its stockholders, dated as of
December 12, 2007.(4)
|
10.8
|
Amendment
No. 2 to Patent License and Assignment Agreement by and between
VirnetX, Inc. and Science Applications International Corporation, dated as
of March 12, 2008. (5)
|
10.9
|
IP
Brokerage Agreement by and between ipCapital Group, Inc. and VirnetX,
Inc., effective as of March 13, 2008. (5)
|
10.10
|
Engagement
Letter by and between VirnetX Holding Corporation and ipCapital Group,
Inc. dated March 12, 2008. (5)
|
10.11
|
2007
Stock Plan and related agreements. (6)
|
10.12
|
Lease
Agreement by and between the Company and Granite Creek Business Center,
dated as of March 15, 2006, as amended in April 2007 and April 2008.
(7)
|
10.13
|
Engagement
Letter dated June 9, 2009, by and between McKool Smith, a professional
corporation, and the Company. (8)
|
21.1
|
Subsidiaries
of VirnetX Holding Corporation. (7)
|
23.2
|
Consent
of Farber Hass Hurley & McEwen, LLP, Independent
Auditors.
|
23.2
|
Consent
of Orrick, Herrington & Sutcliffe LLP. (contained in
Exhibit 5.1)
|
24.1
|
Power
of Attorney. *
|
*
|
Previously
filed.
|
|
(1)
|
Incorporated
by reference to the Company’s Form 8-K (Commission File No.
001-33852) filed with the Securities and Exchange Commission on November
1, 2007.
|
|
(2)
|
Incorporated
by reference to the Company’s Form 8-K (Commission File No.
001-33852) filed with the Securities and Exchange Commission on November
1, 2007.
|
|
(3)
|
Incorporated
by reference to the Company’s Form 8-K (Commission File No.
001-33852) filed with the Securities and Exchange Commission on September
3, 2009.
|
|
(4)
|
Incorporated
herein by reference to the Company’s Registration Statement on Form SB-2/A
filed with the Securities and Exchange Commission on December 17,
2007.
|
|
(5)
|
Incorporated
by reference to the Company’s Form 8-K (Commission File No.
001-33852) filed with the Securities and Exchange Commission on
March 18, 2008.
|
|
(6)
|
Incorporated
herein by reference to the Company’s Registration Statement on Form S-8
filed with the Securities and Exchange Commission on March 25,
2008.
|
|
(7)
|
Incorporated
by reference to the Company’s Form 10-K (Commission File No.
001-33852) filed with the Securities and Exchange Commission on March 31,
2009.
|
|
(8)
|
Incorporated
by reference to the Company’s Form 10-Q (Commission File No.
001-33852) filed with the Securities and Exchange Commission on August 10,
2009.
|
ORRICK,
HERRINGTON & SUTCLIFFE LLP
1000
MARSH ROAD
MENLO
PARK, CA 94025-1015
tel +1-650-614-7400
fax +1-650-614-7401
www.orrick.com
|
VirnetX
Holding Corporation
5615
Scotts Valley Drive, Suite 110
Scotts
Valley, California 95066
|
|
Re:
|
Registration
Statement on Form S-1
|
Very
truly yours,
/s/
Orrick, Herrington & Sutcliffe LLP
Orrick,
Herrington & Sutcliffe
LLP
|